{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 226698, "items": [{"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T04:56:41Z", "timestamp": 1574225801370}, "reference-count": 17, "publisher": "Springer Science and Business Media LLC", "issue": "2", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2006, 8, 17]], "date-time": "2006-08-17T00:00:00Z", "timestamp": 1155772800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Psychopharmacology"], "published-print": {"date-parts": [[2006, 10]]}, "DOI": "10.1007/s00213-006-0490-4", "type": "journal-article", "created": {"date-parts": [[2006, 8, 16]], "date-time": "2006-08-16T13:10:06Z", "timestamp": 1155733806000}, "page": "244-251", "source": "Crossref", "is-referenced-by-count": 96, "title": ["WAY-100635 is a potent dopamine D4 receptor agonist"], "prefix": "10.1007", "volume": "188", "author": [{"given": "Benjamin R.", "family": "Chemel", "sequence": "first", "affiliation": []}, {"given": "Bryan L.", "family": "Roth", "sequence": "additional", "affiliation": []}, {"given": "Blaine", "family": "Armbruster", "sequence": "additional", "affiliation": []}, {"given": "Val J.", "family": "Watts", "sequence": "additional", "affiliation": []}, {"given": "David E.", "family": "Nichols", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2006, 8, 17]]}, "reference": [{"key": "490_CR1", "doi-asserted-by": "crossref", "first-page": "15", "DOI": "10.1016/S0924-977X(97)00100-4", "volume": "9", "author": "S Ahlenius", "year": "1999", "unstructured": "Ahlenius S, Henriksson I, Magnusson O, Salmi P (1999) In vivo intrinsic efficacy of the 5-HT1A receptor antagonists NAD-299, WAY-100,635 and (S)-(-)-UH-301 at rat brain monoamine receptors. Eur Neuropsychopharmacol 9:15\u201319", "journal-title": "Eur Neuropsychopharmacol"}, {"key": "490_CR2", "doi-asserted-by": "crossref", "first-page": "3099", "DOI": "10.1016/0006-2952(73)90196-2", "volume": "22", "author": "Y Cheng", "year": "1973", "unstructured": "Cheng Y, Prusoff WH (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099\u20133108", "journal-title": "Biochem Pharmacol"}, {"key": "490_CR3", "first-page": "441", "volume": "27", "author": "IA Cliffe", "year": "2000", "unstructured": "Cliffe IA (2000) A retrospect on the discovery of WAY-100635 and the prospect for improved 5-HT(1A) receptor PET radioligands. Nucl Med Biol 27:441\u2013447", "journal-title": "Trends Pharmacol Sci"}, {"key": "490_CR4", "doi-asserted-by": "crossref", "first-page": "41", "DOI": "10.1016/0165-6147(93)90185-M", "volume": "14", "author": "A Fletcher", "year": "1993", "unstructured": "Fletcher A, Cliffe IA, Dourish CT (1993) Silent 5-HT1A receptor antagonists: utility as research tools and therapeutic agents. Trends Pharmacol Sci 14:41\u201348", "journal-title": "Trends Pharmacol Sci"}, {"key": "490_CR5", "doi-asserted-by": "crossref", "first-page": "337", "DOI": "10.1016/0166-4328(96)00118-0", "volume": "73", "author": "A Fletcher", "year": "1996", "unstructured": "Fletcher A, Forster EA, Bill DJ, Brown G, Cliffe IA, Hartley JE, Jones DE, McLenachan A, Stanhope KJ, Critchley DJ, Childs KJ, Middlefell VC, Lanfumey L, Corradetti R, Laporte AM, Gozlan H, Hamon M, Dourish CT (1996) Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist. Behav Brain Res 73:337\u2013353", "journal-title": "Behav Brain Res"}, {"key": "490_CR6", "doi-asserted-by": "crossref", "first-page": "81", "DOI": "10.1016/0014-2999(95)00234-C", "volume": "281", "author": "EA Forster", "year": "1995", "unstructured": "Forster EA, Cliffe IA, Bill DJ, Dover GM, Jones D, Reilly Y, Fletcher A (1995) A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635. Eur J Pharmacol 281:81\u201388", "journal-title": "Eur J Pharmacol"}, {"key": "490_CR7", "first-page": "216", "volume": "283", "author": "L Johansson", "year": "1997", "unstructured": "Johansson L, Sohn D, Thorberg SO, Jackson DM, Kelder D, Larsson LG, Renyi L, Ross SB, Wallsten C, Eriksson H, Hu PS, Jerning E, Mohell N, Westlind-Danielsson A (1997) The pharmacological characterization of a novel selective 5-hydroxytryptamine1A receptor antagonist, NAD-299. J Pharmacol Exp Ther 283:216\u2013225", "journal-title": "J Pharmacol Exp Ther"}, {"key": "490_CR8", "doi-asserted-by": "crossref", "first-page": "112", "DOI": "10.1016/j.neuropharm.2005.02.004", "volume": "49", "author": "M Nakane", "year": "2005", "unstructured": "Nakane M, Cowart MD, Hsieh GC, Miller L, Uchic ME, Chang R, Terranova MA, Donnelly-Roberts DL, Namovic MT, Miller TR, Wetter JM, Marsh K, Stewart AO, Brioni JD, Moreland RB (2005) 2-[4-(3,4-Dimethylphenyl)piperazin-1-ylmethyl]-1H benzoimidazole (A-381393), a selective dopamine D4 receptor antagonist. Neuropharmacology 49:112\u2013121", "journal-title": "Neuropharmacology"}, {"key": "490_CR9", "doi-asserted-by": "crossref", "first-page": "627", "DOI": "10.1016/0969-8051(96)00061-3", "volume": "23", "author": "S Osman", "year": "1996", "unstructured": "Osman S, Lundkvist C, Pike VW, Halldin C, McCarron JA, Swahn CG, Ginovart N, Luthra SK, Bench CJ, Grasby PM, Wikstrom H, Barf T, Cliffe IA, Fletcher A, Farde L (1996) Characterization of the radioactive metabolites of the 5-HT1A receptor radioligand, [O-methyl-11C]WAY-100635, in monkey and human plasma by HPLC: comparison of the behaviour of an identified radioactive metabolite with parent radioligand in monkey using PET. Nucl Med Biol 23:627\u2013634", "journal-title": "Nucl Med Biol"}, {"key": "490_CR10", "doi-asserted-by": "crossref", "first-page": "113", "DOI": "10.1007/s002590000394", "volume": "28", "author": "J Passchier", "year": "2001", "unstructured": "Passchier J, van Waarde A (2001) Visualisation of serotonin-1A (5-HT1A) receptors in the central nervous system. Eur J Nucl Med 28:113\u2013129", "journal-title": "Eur J Nucl Med"}, {"key": "490_CR11", "doi-asserted-by": "crossref", "first-page": "R1", "DOI": "10.1016/0014-2999(95)00438-Q", "volume": "283", "author": "VW Pike", "year": "1995", "unstructured": "Pike VW, McCarron JA, Lammerstma AA, Hume SP, Poole K, Grasby PM, Malizia A, Cliffe IA, Fletcher A, Bench CJ (1995) First delineation of 5-HT1A receptors in human brain with PET and [11C]WAY-100635. Eur J Pharmacol 283:R1\u2013R3", "journal-title": "Eur J Pharmacol"}, {"key": "490_CR12", "doi-asserted-by": "crossref", "first-page": "R5", "DOI": "10.1016/0014-2999(96)00079-9", "volume": "301", "author": "VW Pike", "year": "1996", "unstructured": "Pike VW, McCarron JA, Lammertsma AA, Osman S, Hume SP, Sargent PA, Bench CJ, Cliffe IA, Fletcher A, Grasby PM (1996) Exquisite delineation of 5-HT1A receptors in human brain with PET and [carbonyl-11 C]WAY-100635. Eur J Pharmacol 301:R5\u2013R7", "journal-title": "Eur J Pharmacol"}, {"key": "490_CR13", "doi-asserted-by": "crossref", "first-page": "11934", "DOI": "10.1073/pnas.182234399", "volume": "99", "author": "BL Roth", "year": "2002", "unstructured": "Roth BL, Baner K, Westkaemper R, Siebert D, Rice KC, Steinberg S, Ernsberger P, Rothman RB (2002) Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proc Natl Acad Sci U S A 99:11934\u201311939", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "490_CR14", "doi-asserted-by": "crossref", "first-page": "1400", "DOI": "10.1038/sj.npp.1300203", "volume": "28", "author": "DA Shapiro", "year": "2003", "unstructured": "Shapiro DA, Renock S, Arrington E, Chiodo LA, Liu LX, Sibley DR, Roth BL, Mailman R (2003) Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. Neuropsychopharmacology 28:1400\u20131411", "journal-title": "Neuropsychopharmacology"}, {"key": "490_CR15", "first-page": "966", "volume": "50", "author": "VJ Watts", "year": "1996", "unstructured": "Watts VJ, Neve KA (1996) Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors. Mol Pharmacol 50:966\u2013976", "journal-title": "Mol Pharmacol"}, {"key": "490_CR16", "doi-asserted-by": "crossref", "first-page": "83", "DOI": "10.1007/s002130050810", "volume": "141", "author": "VJ Watts", "year": "1999", "unstructured": "Watts VJ, Vu MN, Wiens BL, Jovanovic V, Van Tol HH, Neve KA (1999) Short- and long-term heterologous sensitization of adenylate cyclase by D4 dopamine receptors. Psychopharmacology (Berl) 141:83\u201392", "journal-title": "Psychopharmacology (Berl)"}, {"key": "490_CR17", "doi-asserted-by": "crossref", "first-page": "1406", "DOI": "10.1021/jm00036a003", "volume": "37", "author": "ZP Zhuang", "year": "1994", "unstructured": "Zhuang ZP, Kung MP, Kung HF (1994) Synthesis and evaluation of 4-(2\u2032-methoxyphenyl)-1-[2\u2032-[N-(2\u2032\u2032-pyridinyl)-p-iodobenzamido]ethyl]piperazine (p-MPPI): a new iodinated 5-HT1A ligand. J Med Chem 37:1406\u20131407", "journal-title": "J Med Chem"}], "container-title": ["Psychopharmacology"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s00213-006-0490-4.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s00213-006-0490-4/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s00213-006-0490-4", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 23]], "date-time": "2019-05-23T16:31:26Z", "timestamp": 1558629086000}, "score": 117.946945, "issued": {"date-parts": [[2006, 8, 17]]}, "references-count": 17, "journal-issue": {"published-print": {"date-parts": [[2006, 10]]}, "issue": "2"}, "alternative-id": ["490"], "URL": "http://dx.doi.org/10.1007/s00213-006-0490-4", "relation": {"cites": []}, "ISSN": ["0033-3158", "1432-2072"], "issn-type": [{"value": "0033-3158", "type": "print"}, {"value": "1432-2072", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T19:21:26Z", "timestamp": 1574277686857}, "reference-count": 20, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Behavioural Pharmacology"], "published-print": {"date-parts": [[2009, 2]]}, "DOI": "10.1097/fbp.0b013e3283242f1a", "type": "journal-article", "created": {"date-parts": [[2009, 1, 29]], "date-time": "2009-01-29T08:15:57Z", "timestamp": 1233216957000}, "page": "114-118", "source": "Crossref", "is-referenced-by-count": 21, "title": ["WAY 100635 produces discriminative stimulus effects in rats mediated by dopamine D4 receptor activation"], "prefix": "10.1097", "volume": "20", "author": [{"given": "Danuta", "family": "Marona-Lewicka", "sequence": "first", "affiliation": []}, {"given": "David E.", "family": "Nichols", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Behavioural Pharmacology"], "language": "en", "link": [{"URL": "http://journals.lww.com/behaviouralpharm/Fulltext/10.1097/FBP.0b013e3283242f1a", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 2, 17]], "date-time": "2019-02-17T07:27:28Z", "timestamp": 1550388448000}, "score": 53.701355, "subtitle": [""], "issued": {"date-parts": [[2009, 2]]}, "references-count": 20, "journal-issue": {"issue": "1"}, "URL": "http://dx.doi.org/10.1097/fbp.0b013e3283242f1a", "ISSN": ["0955-8810"], "issn-type": [{"value": "0955-8810", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T23:06:17Z", "timestamp": 1574377577715}, "reference-count": 64, "publisher": "Springer Science and Business Media LLC", "issue": "2", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2008, 7, 6]], "date-time": "2008-07-06T00:00:00Z", "timestamp": 1215302400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Psychopharmacology"], "published-print": {"date-parts": [[2009, 4]]}, "DOI": "10.1007/s00213-008-1238-0", "type": "journal-article", "created": {"date-parts": [[2008, 7, 5]], "date-time": "2008-07-05T20:08:14Z", "timestamp": 1215288494000}, "page": "265-277", "source": "Crossref", "is-referenced-by-count": 20, "title": ["Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI"], "prefix": "10.1007", "volume": "203", "author": [{"given": "Danuta", "family": "Marona-Lewicka", "sequence": "first", "affiliation": []}, {"given": "Benjamin R.", "family": "Chemel", "sequence": "additional", "affiliation": []}, {"given": "David E.", "family": "Nichols", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2008, 7, 6]]}, "reference": [{"key": "1238_CR1", "doi-asserted-by": "crossref", "first-page": "302", "DOI": "10.1016/S0165-0173(99)00046-6", "volume": "31", "author": "GK Aghajanian", "year": "2000", "unstructured": "Aghajanian GK, Marek GJ (2000) Serotonin model of schizophrenia: emerging role of glutamate mechanisms. Brain Res Brain Res Rev 31:302\u2013312", "journal-title": "Brain Res Brain Res Rev"}, {"key": "1238_CR2", "doi-asserted-by": "crossref", "first-page": "296", "DOI": "10.1016/j.pharmthera.2006.08.004", "volume": "113", "author": "KD Alex", "year": "2007", "unstructured": "Alex KD, Pehek EA (2007) Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol Ther 113:296\u2013320", "journal-title": "Pharmacol Ther"}, {"key": "1238_CR3", "doi-asserted-by": "crossref", "first-page": "1597", "DOI": "10.1111/j.1471-4159.2005.03485.x", "volume": "95", "author": "A Bortolozzi", "year": "2005", "unstructured": "Bortolozzi A, az-Mataix L, Scorza MC, Celada P, Artigas F (2005) The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity. J Neurochem 95:1597\u20131607", "journal-title": "J Neurochem"}, {"key": "1238_CR4", "doi-asserted-by": "crossref", "first-page": "6758", "DOI": "10.1073/pnas.0308292101", "volume": "101", "author": "JD Brioni", "year": "2004", "unstructured": "Brioni JD, Moreland RB, Cowart M, Hsieh GC, Stewart AO, Hedlund P, Donnelly-Roberts DL, Nakane M, Lynch JJ, Kolasa T, Polakowski JS, Osinski MA, Marsh K, Andersson K-E, Sullivan JP (2004) Activation of dopamine D4 receptors by ABT-724 induces penile erection in rats. Proc Nat Acad Sci 101:6758\u20136763", "journal-title": "Proc Nat Acad Sci"}, {"key": "1238_CR5", "doi-asserted-by": "crossref", "first-page": "244", "DOI": "10.1007/s00213-006-0490-4", "volume": "188", "author": "BR Chemel", "year": "2006", "unstructured": "Chemel BR, Roth BL, Armbruster B, Watts VJ, Nichols DE (2006a) WAY-100635 is a potent dopamine D4 receptor agonist. Psychopharmacology (Berl) 188:244\u2013251", "journal-title": "Psychopharmacology (Berl)"}, {"key": "1238_CR6", "unstructured": "Chemel BR, Roth BL, Armbruster B, Watts VJ, Marona-Lewicka D, Nichols DE (2006b) The \u201cselective\u201d 5-HT1A antagonist WAY-100635 and its metabolite WAY-100634, are potent dopamine D4 receptor agonists. ACNP, 45th Annual Meeting, Hollywood, FL", "DOI": "10.1007/s00213-006-0490-4", "doi-asserted-by": "crossref"}, {"key": "1238_CR7", "doi-asserted-by": "crossref", "first-page": "3099", "DOI": "10.1016/0006-2952(73)90196-2", "volume": "22", "author": "Y Cheng", "year": "1973", "unstructured": "Cheng Y, Prusoff WH (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099\u20133108", "journal-title": "Biochem Pharmacol"}, {"key": "1238_CR8", "first-page": "206", "volume": "221", "author": "FC Colpaert", "year": "1982", "unstructured": "Colpaert FC, Niemegeers CJ, Janssen PA (1982) A drug discrimination analysis of lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, a LSD-antagonist. J Pharmacol Exp Ther 221:206\u2013214", "journal-title": "J Pharmacol Exp Ther"}, {"key": "1238_CR9", "doi-asserted-by": "crossref", "first-page": "3853", "DOI": "10.1021/jm030505a", "volume": "47", "author": "M Cowart", "year": "2004", "unstructured": "Cowart M, Latshaw SP, Bhatia P, Daanen JF, Rohde J, Nelson SL, Patel M, Kolasa T, Nakane M, Uchic ME, Miller LN, Terranova MA, Chang R, Donnelly-Roberts DL, Namovic MT, Hollingsworth PR, Martino BR, Lynch JJ III, Sullivan JP, Hsieh GC, Moreland RB, Brioni JD, Stewart AO (2004) Discovery of 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole (ABT-724), a dopaminergic agent with a novel mode of action for the potential treatment of erectile dysfunction. J Med Chem. 47:3853\u20133864", "journal-title": "J Med Chem."}, {"key": "1238_CR10", "doi-asserted-by": "crossref", "first-page": "475", "DOI": "10.1111/j.1471-4159.2007.04768.x", "volume": "103", "author": "J Almeida de", "year": "2007", "unstructured": "de Almeida J, Mengod G (2007) Quantitative analysis of glutamatergic and GABAergic neurons expressing 5-HT(2A) receptors in human and monkey prefrontal cortex. J Neurochem 103:475\u2013486", "journal-title": "J Neurochem"}, {"key": "1238_CR11", "doi-asserted-by": "crossref", "first-page": "337", "DOI": "10.1016/0166-4328(96)00118-0", "volume": "73", "author": "A Fletcher", "year": "1996", "unstructured": "Fletcher A, Forster EA, Bill DJ, Brown G, Cliffe IA, Hartley JE, Jones DE, McLenachan A, Stanhope KJ, Critchley DJ, Childs KJ, Middlefell VC, Lanfumey L, Corradetti R, Laporte AM, Gozlan H, Hamon M, Dourish CT (1996) Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist. Behav Brain Res 73:337\u2013353", "journal-title": "Behav Brain Res"}, {"key": "1238_CR12", "doi-asserted-by": "crossref", "first-page": "81", "DOI": "10.1016/0014-2999(95)00234-C", "volume": "281", "author": "EA Forster", "year": "1995", "unstructured": "Forster EA, Cliffe IA, Bill DJ, Dover GM, Jones D, Reilly Y, Fletcher A (1995) A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635. Eur J Pharmacol 281:81\u201388", "journal-title": "Eur J Pharmacol"}, {"key": "1238_CR13", "author": "DX Freedman", "first-page": "203", "year": "1984", "unstructured": "Freedman DX (1984) LSD: The bridge from human to animal. In: Jacobs BL (ed) Hallucinogens: neurochemical, behavioral, and clinical perspectives. Raven, New York, pp 203\u2013226", "volume-title": "Hallucinogens: neurochemical, behavioral, and clinical perspectives"}, {"key": "1238_CR14", "doi-asserted-by": "crossref", "first-page": "319", "DOI": "10.1016/S0896-6273(01)00285-9", "volume": "30", "author": "JM Fuster", "year": "2001", "unstructured": "Fuster JM (2001) The prefrontal cortex\u2014an update: time is of the essence. Neuron 30:319\u2013333", "journal-title": "Neuron"}, {"key": "1238_CR15", "doi-asserted-by": "crossref", "first-page": "825", "DOI": "10.1016/0024-3205(86)90461-3", "volume": "39", "author": "RA Glennon", "year": "1986", "unstructured": "Glennon RA (1986) Discriminative stimulus properties of the serotonergic agent 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI). Life Sci 39:825\u2013830", "journal-title": "Life Sci"}, {"key": "1238_CR16", "doi-asserted-by": "crossref", "first-page": "2505", "DOI": "10.1016/0024-3205(84)90436-3", "volume": "35", "author": "RA Glennon", "year": "1984", "unstructured": "Glennon RA, Titeler M, McKenney JD (1984) Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sci 35:2505\u20132511", "journal-title": "Life Sci"}, {"key": "1238_CR17", "doi-asserted-by": "crossref", "first-page": "151", "DOI": "10.1016/S0304-3940(02)00182-9", "volume": "326", "author": "JL Griffiths", "year": "2002", "unstructured": "Griffiths JL, Lovick TA (2002) Co-localization of 5-HT 2A -receptor- and GABA-immunoreactivity in neurones in the periaqueductal grey matter of the rat. Neurosci Lett 326:151\u2013154", "journal-title": "Neurosci Lett"}, {"key": "1238_CR18", "doi-asserted-by": "crossref", "first-page": "948", "DOI": "10.1124/mol.104.001404", "volume": "66", "author": "Z Gu", "year": "2004", "unstructured": "Gu Z, Yan Z (2004) Biodirectional regulation of Ca2+/calmodulin-dependent protein kinase II activity by dopamine D4 receptors in prefrontal cortex. Mol Pharmacol 66:948\u2013955", "journal-title": "Mol Pharmacol"}, {"key": "1238_CR19", "first-page": "813", "volume": "69", "author": "Z Gu", "year": "2006", "unstructured": "Gu Z, Jiang Q, Yuen EY, Yan Z (2006) Activation of dopamine D4 receptors induces synaptic translocation of Ca2+/calmodulin-dependent protein kinase II in cultured prefrontal cortical neurons. Mol Pharmacol 69:813\u2013822", "journal-title": "Mol Pharmacol"}, {"key": "1238_CR20", "doi-asserted-by": "crossref", "first-page": "204", "DOI": "10.1016/0006-8993(95)00865-N", "volume": "698", "author": "J Ichikawa", "year": "1995", "unstructured": "Ichikawa J, Meltzer HY (1995) DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat striatum. Brain Res 698:204\u2013208", "journal-title": "Brain Res"}, {"key": "1238_CR21", "doi-asserted-by": "crossref", "first-page": "S273", "DOI": "10.1016/S0924-977X(97)88903-1", "volume": "7", "author": "A Klodzinska", "year": "1997", "unstructured": "Klodzinska A, Chojnacka-Wojcik E (1997) Involvement of 5-HT2A receptors in mediating of the discriminative stimulus properties of DOI in rats. Eur Neuropsychopharmacol 7:S273", "journal-title": "Eur Neuropsychopharmacol"}, {"key": "1238_CR22", "first-page": "99", "volume": "96", "author": "JT Litchfield Jr", "year": "1949", "unstructured": "Litchfield JT Jr, Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96:99\u2013112", "journal-title": "J Pharmacol Exp Ther"}, {"key": "1238_CR23", "doi-asserted-by": "crossref", "first-page": "693", "DOI": "10.1046/j.1471-4159.2000.740693.x", "volume": "74", "author": "G Lucas", "year": "2000", "unstructured": "Lucas G, Spampinato U (2000) Role of striatal serotonin2A and serotonin2C receptor subtypes in the control of in vivo dopamine outflow in the rat striatum. J Neurochem 74:693\u2013701", "journal-title": "J Neurochem"}, {"key": "1238_CR24", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/0014-2999(94)90051-5", "volume": "258", "author": "D Marona-Lewicka", "year": "1994", "unstructured": "Marona-Lewicka D, Nichols DE (1994) Behavioral effects of the highly selective serotonin releasing agent 5-methoxy-6-methyl-2-aminoindan. Eur J Pharmacol 258:1\u201313", "journal-title": "Eur J Pharmacol"}, {"key": "1238_CR25", "doi-asserted-by": "crossref", "first-page": "1471", "DOI": "10.1016/S0028-3908(97)00106-8", "volume": "36", "author": "D Marona-Lewicka", "year": "1997", "unstructured": "Marona-Lewicka D, Nichols DE (1997) 5-HT2A/2C receptor agonists potentiate the discriminative cue of (+)-amphetamine in the rat. Neuropharmacology 36:1471\u20131475", "journal-title": "Neuropharmacology"}, {"key": "1238_CR26", "doi-asserted-by": "crossref", "first-page": "453", "DOI": "10.1016/j.pbb.2007.06.001", "volume": "87", "author": "D Marona-Lewicka", "year": "2007", "unstructured": "Marona-Lewicka D, Nichols DE (2007) Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action. Pharmacol Biochem Behav 87:453\u2013461", "journal-title": "Pharmacol Biochem Behav"}, {"key": "1238_CR27", "doi-asserted-by": "crossref", "first-page": "427", "DOI": "10.1007/s00213-005-2183-9", "volume": "180", "author": "D Marona-Lewicka", "year": "2005", "unstructured": "Marona-Lewicka D, Thisted RA, Nichols DE (2005) Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis. Psychopharmacology (Berl) 180:427\u2013435", "journal-title": "Psychopharmacology (Berl)"}, {"key": "1238_CR28", "doi-asserted-by": "crossref", "first-page": "15", "DOI": "10.1016/j.ejphar.2007.07.015", "volume": "574", "author": "J-C Martel", "year": "2007", "unstructured": "Martel J-C, Leduc N, Ormiere A-M, Foucillon V, Danty N, Culie C, Cussac D, Newman-Tancredi A (2007) WAY-100635 has high selectivity for serotonin 5-HT1A versus dopamine D4 receptors. Eur J Pharmacol 574:15\u201319", "journal-title": "Eur J Pharmacol"}, {"key": "1238_CR29", "doi-asserted-by": "crossref", "first-page": "106S", "DOI": "10.1016/S0893-133X(99)00046-9", "volume": "21", "author": "HY Meltzer", "year": "1999", "unstructured": "Meltzer HY (1999) The role of serotonin in antipsychotic drug action. Neuropsychopharmacology 21:106S\u2013115S", "journal-title": "Neuropsychopharmacology"}, {"key": "1238_CR30", "doi-asserted-by": "crossref", "first-page": "107", "DOI": "10.1016/S0306-4522(02)00580-8", "volume": "116", "author": "LA Miner", "year": "2003", "unstructured": "Miner LA, Backstrom JR, Sanders-Bush E, Sesack SR (2003) Ultrastructural localization of serotonin2A receptors in the middle layers of the rat prelimbic prefrontal cortex. Neuroscience 116:107\u2013117", "journal-title": "Neuroscience"}, {"key": "1238_CR31", "doi-asserted-by": "crossref", "first-page": "245", "DOI": "10.1038/381245a0", "volume": "381", "author": "L Mrzljak", "year": "1996", "unstructured": "Mrzljak L, Bergson C, Pappy M, Huff R, Levenson R, Goldman-Rakic PS (1996) Localization of dopamine D4 receptors in GABAergic neurons of the primate brain. Nature 381:245\u2013248", "journal-title": "Nature"}, {"key": "1238_CR32", "first-page": "239", "volume": "291", "author": "P Munzar", "year": "1999", "unstructured": "Munzar P, Laufert MD, Kutkat SW, Novakova J, Goldbertg SR (1999) Effects of various serotonin agonists, antagonists, and uptake inhibitors on the discriminative stimulus effects of methamphetamine in rats. J Pharmacol Exp Ther 291:239\u2013250", "journal-title": "J Pharmacol Exp Ther"}, {"key": "1238_CR33", "doi-asserted-by": "crossref", "first-page": "75", "DOI": "10.1016/S0014-2999(01)01598-9", "volume": "436", "author": "P Munzar", "year": "2002", "unstructured": "Munzar P, Justinova Z, Kutkat SW, Goldberg SR (2002) Differential involvement of 5-HT2A receptors in the discriminative-stimulus effects of cocaine and methamphetamine. Eur J Pharmacol 436:75\u201382", "journal-title": "Eur J Pharmacol"}, {"key": "1238_CR34", "doi-asserted-by": "crossref", "first-page": "112", "DOI": "10.1016/j.neuropharm.2005.02.004", "volume": "49", "author": "M Nakane", "year": "2005", "unstructured": "Nakane M, Cowart MD, Hsieh GC, Miller L, Uchic ME, Chang R, Terranova MA, Donnelly-Roberts DL, Namovic MT, Miller TR, Wetter JM, Marsh K, Stewart AO, Brioni JD, Moreland RB (2005) 2-[4-(3,4-Dimethylphenyl)piperazin-1-ylmethyl]-1H benzoimidazole (A-381393), a selective dopamine D4 receptor antagonist. Neuropharmacology 49:112\u2013121", "journal-title": "Neuropharmacology"}, {"key": "1238_CR35", "first-page": "181", "volume": "282", "author": "A Newman-Tancredi", "year": "1997", "unstructured": "Newman-Tancredi A, Audinot V, Chaput C, Verriele L, Millan MJ (1997) [35S]Guanosine-5\u00a2-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents. J Pharmacol Exp Ther 282:181\u2013191", "journal-title": "J Pharmacol Exp Ther"}, {"key": "1238_CR36", "doi-asserted-by": "crossref", "first-page": "131", "DOI": "10.1016/j.pharmthera.2003.11.002", "volume": "101", "author": "DE Nichols", "year": "2004", "unstructured": "Nichols DE (2004) Hallucinogens. Pharmacol Ther 101:131\u2013181", "journal-title": "Pharmacol Ther"}, {"key": "1238_CR37", "first-page": "636", "volume": "283", "author": "S Patel", "year": "1997", "unstructured": "Patel S, Freedman S, Chapman KL, Emms F, Fletcher AE, Knowles M, Marwood R, McAllister G, Myers J, Curtis N, Kulagowski JJ, Leeson PD, Ridgill M, Graham M, Matheson S, Rathbone D, Watt AP, Bristow LJ, Rupniak NM, Baskin E, Lynch JJ, Ragan CI (1997) Biological profile of L-745,870, a selective antagonist with high affinity for the dopamine D4 receptor. J Pharmacol Exp Ther 283:636\u2013647", "journal-title": "J Pharmacol Exp Ther"}, {"key": "1238_CR38", "doi-asserted-by": "crossref", "first-page": "12", "DOI": "10.1002/(SICI)1098-2396(199609)24:1<12::AID-SYN2>3.0.CO;2-J", "volume": "24", "author": "EA Pehek", "year": "1996", "unstructured": "Pehek EA (1996) Local infusion of the serotonin antagonists ritanserin or ICS 205,930 increases in vivo dopamine release in the rat medial prefrontal cortex. Synapse 24:12\u201318", "journal-title": "Synapse"}, {"key": "1238_CR39", "doi-asserted-by": "crossref", "first-page": "51", "DOI": "10.1016/S0006-8993(00)03004-3", "volume": "888", "author": "EA Pehek", "year": "2001", "unstructured": "Pehek EA, McFarlane HG, Maguschak K, Price B, Pluto CP (2001) M100,907, a selective 5-HT(2A) antagonist, attenuates dopamine release in the rat medial prefrontal cortex. Brain Res 888:51\u201359", "journal-title": "Brain Res"}, {"key": "1238_CR40", "doi-asserted-by": "crossref", "first-page": "265", "DOI": "10.1038/sj.npp.1300819", "volume": "31", "author": "EA Pehek", "year": "2006", "unstructured": "Pehek EA, Nocjar C, Roth BL, Byrd TA, Mabrouk OS (2006) Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex. Neuropsychopharmacology 31:265\u2013277", "journal-title": "Neuropsychopharmacology"}, {"key": "1238_CR41", "doi-asserted-by": "crossref", "first-page": "983", "DOI": "10.1016/S0028-3908(98)00092-6", "volume": "37", "author": "G Pillai", "year": "1998", "unstructured": "Pillai G, Brown NA, McAllister G, Milligan G, Seabrook GR (1998) Human D2 and D4 dopamine receptors couple through betagamma G-protein subunits to inwardly rectifying K+ channels (GIRK1) in a Xenopus oocyte expression system: selective antagonism by L-741,626 and L-745,870 respectively. Neuropharmacol 37:983\u2013987", "journal-title": "Neuropharmacol"}, {"key": "1238_CR42", "doi-asserted-by": "crossref", "first-page": "197", "DOI": "10.1007/s00213-005-0068-6", "volume": "182", "author": "CJ Reissig", "year": "2005", "unstructured": "Reissig CJ, Eckler JR, Rabin RA, Winter JC (2005) The 5-HT1A receptor and the stimulus effects of LSD in the rat. Psychopharmacology (Berl) 182:197\u2013204", "journal-title": "Psychopharmacology (Berl)"}, {"key": "1238_CR43", "doi-asserted-by": "crossref", "first-page": "312", "DOI": "10.1016/j.pbb.2007.09.011", "volume": "88", "author": "CJ Reissig", "year": "2008", "unstructured": "Reissig CJ, Eckler JR, Rabin RA, Rice KC, Winter JC (2008) The stimulus effects of 8-OH-DPAT: Evidence for a 5-HT(2A) receptor-mediated component. Pharmacol Biochem Behav 88:312\u2013317", "journal-title": "Pharmacol Biochem Behav"}, {"key": "1238_CR44", "doi-asserted-by": "crossref", "first-page": "29", "DOI": "10.1016/S0024-3205(00)00911-5", "volume": "68", "author": "E Richelson", "year": "2000", "unstructured": "Richelson E, Souder T (2000) Binding of antipsychotic drugs to human brain receptors. Focus on newer generation compounds. Life Sci 68:29\u201339", "journal-title": "Life Sci"}, {"key": "1238_CR45", "doi-asserted-by": "crossref", "first-page": "365", "DOI": "10.1007/BF02311185", "volume": "120", "author": "BL Roth", "year": "1995", "unstructured": "Roth BL, Tandra S, Burgess LH, Sibley DR, Meltzer HY (1995) D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs. Psychopharmacology (Berl) 120:365\u2013368", "journal-title": "Psychopharmacology (Berl)"}, {"key": "1238_CR46", "doi-asserted-by": "crossref", "first-page": "3756", "DOI": "10.1523/JNEUROSCI.21-11-03756.2001", "volume": "21", "author": "M Rubinstein", "year": "2001", "unstructured": "Rubinstein M, Cepeda C, Hurst RS, Flores-Hernandez J, Ariano MA, Falzone TL, Kozell LB, Meshul CK, Bunzow JR, Low MJ, Levine MS, Grandy DK (2001) Dopamine D4 receptor-deficient mice display cortical hyperexcitability. J Neurosci 21:3756\u20133763", "journal-title": "J Neurosci"}, {"key": "1238_CR47", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/j.pneurobio.2004.05.006", "volume": "74", "author": "JK Seamans", "year": "2004", "unstructured": "Seamans JK, Yang CR (2004) The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol 74:1\u201358", "journal-title": "Prog Neurobiol"}, {"key": "1238_CR48", "doi-asserted-by": "crossref", "first-page": "3628", "DOI": "10.1523/JNEUROSCI.21-10-03628.2001", "volume": "21", "author": "JK Seamans", "year": "2001", "unstructured": "Seamans JK, Gorelova N, Durstewitz D, Yang CR (2001) Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons. J Neurosci 21:3628\u20133638", "journal-title": "J Neurosci"}, {"key": "1238_CR49", "doi-asserted-by": "crossref", "first-page": "93", "DOI": "10.1016/S0893-133X(96)00187-X", "volume": "16", "author": "P Seeman", "year": "1997", "unstructured": "Seeman P, Corbett R, Van Tol HHM (1997) Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors. Neuropsychopharmacology 16:93\u2013110", "journal-title": "Neuropsychopharmacology"}, {"key": "1238_CR50", "doi-asserted-by": "crossref", "first-page": "248", "DOI": "10.1007/s002130051000", "volume": "144", "author": "RL Smith", "year": "1999", "unstructured": "Smith RL, Barrett RJ, Sanders-Bush E (1999) Mechanism of tolerance development to 2,5-dimethoxy-4-iodoamphetamine in rats: down-regulation of the 5-HT2A, but not 5-HT2C, receptor. Psychopharmacology 144:248\u2013254", "journal-title": "Psychopharmacology"}, {"key": "1238_CR51", "doi-asserted-by": "crossref", "first-page": "610", "DOI": "10.1038/350610a0", "volume": "350", "author": "HH Tol Van", "year": "1991", "unstructured": "Van Tol HH, Bunzow JR, Guan HC, Sunahara RK, Seeman P, Niznik HB, Civelli O (1991) Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 350:610\u2013614", "journal-title": "Nature"}, {"key": "1238_CR52", "doi-asserted-by": "crossref", "first-page": "424", "DOI": "10.1016/S0893-133X(98)00108-0", "volume": "20", "author": "FX Vollenweider", "year": "1999", "unstructured": "Vollenweider FX, Vontobel P, Hell D, Leenders KL (1999) 5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man - A PET study with [11C]raclopride. Neuropsychopharmacology 20:424\u2013433", "journal-title": "Neuropsychopharmacology"}, {"key": "1238_CR53", "doi-asserted-by": "crossref", "first-page": "9185", "DOI": "10.1523/JNEUROSCI.22-21-09185.2002", "volume": "22", "author": "X Wang", "year": "2002", "unstructured": "Wang X, Zhong P, Yan Z (2002) Dopamine D4 receptors modulate GABAergic signaling in pyramidal neurons of prefrontal cortex. J Neurosci 22:9185\u20139193", "journal-title": "J Neurosci"}, {"key": "1238_CR54", "doi-asserted-by": "crossref", "first-page": "9852", "DOI": "10.1523/JNEUROSCI.23-30-09852.2003", "volume": "23", "author": "X Wang", "year": "2003", "unstructured": "Wang X, Zhong P, Gu Z, Yan Z (2003) Regulation of NMDA receptors by dopamine D4 signaling in prefrontal cortex. J Neurosci 23:9852\u20139861", "journal-title": "J Neurosci"}, {"key": "1238_CR55", "first-page": "966", "volume": "50", "author": "VJ Watts", "year": "1996", "unstructured": "Watts VJ, Neve KA (1996) Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors. Mol Pharmacol 50:966\u2013976", "journal-title": "Mol Pharmacol"}, {"key": "1238_CR56", "doi-asserted-by": "crossref", "first-page": "401", "DOI": "10.1007/BF02245940", "volume": "118", "author": "VJ Watts", "year": "1995", "unstructured": "Watts VJ, Lawler CP, Fox DR, Neve KA, Nichols DE, Mailman RB (1995) LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors. Psychopharmacology 118:401\u2013409", "journal-title": "Psychopharmacology"}, {"key": "1238_CR57", "doi-asserted-by": "crossref", "first-page": "83", "DOI": "10.1007/s002130050810", "volume": "141", "author": "VJ Watts", "year": "1999", "unstructured": "Watts VJ, Vu MN, Wiens BL, Jovanovic V, Van Tol HH, Neve KA (1999) Short- and long-term heterologous sensitization of adenylate cyclase by D4 dopamine receptors. Psychopharmacology (Berl) 141:83\u201392", "journal-title": "Psychopharmacology (Berl)"}, {"key": "1238_CR58", "doi-asserted-by": "crossref", "first-page": "165", "DOI": "10.1016/j.ejphar.2007.01.055", "volume": "562", "author": "C Wedemeyer", "year": "2007", "unstructured": "Wedemeyer C, Goutman JD, Avale ME, Franchini LF, Rubinstein M, Calvo DJ (2007) Functional activation by central monoamines of human dopamine D(4) receptor polymorphic variants coupled to GIRK channels in Xenopus oocytes. Eur Pharmacol 562:165\u2013173", "journal-title": "Eur Pharmacol"}, {"key": "1238_CR59", "first-page": "205", "volume": "51", "author": "K Wedzony", "year": "2000", "unstructured": "Wedzony K, Chocyk A, Mackowiak M, Fijal K, Czyrak A (2000) Cortical localization of dopamine D4 receptors in the rat brain\u2014immunocytochemical study. J Physiol Pharmacol 51:205\u2013221", "journal-title": "J Physiol Pharmacol"}, {"key": "1238_CR60", "doi-asserted-by": "crossref", "first-page": "283", "DOI": "10.1016/S0091-3057(99)00063-5", "volume": "64", "author": "JC Winter", "year": "1999", "unstructured": "Winter JC, Fiorella DJ, Timineri DM, Filipink RA, Helsley SE, Rabin RA (1999) Serotonergic receptor subtypes and hallucinogen-induced stimulus control. Pharmacol Biochem Behav 64:283\u2013293", "journal-title": "Pharmacol Biochem Behav"}, {"key": "1238_CR61", "doi-asserted-by": "crossref", "first-page": "499", "DOI": "10.1016/S0361-9230(99)00278-6", "volume": "51", "author": "T Xu", "year": "2000", "unstructured": "Xu T, Pandey SC (2000) Cellular localization of serotonin(2A) (5HT(2A)) receptors in the rat brain. Brain Res Bull 51:499\u2013505", "journal-title": "Brain Res Bull"}, {"key": "1238_CR62", "doi-asserted-by": "crossref", "first-page": "75", "DOI": "10.1016/S0361-9230(99)00208-7", "volume": "51", "author": "QS Yan", "year": "2000", "unstructured": "Yan QS (2000) Activation of 5-HT2A/2C receptors within the nucleus accumbens increases local dopaminergic transmission. Brain Res Bull 51:75\u201381", "journal-title": "Brain Res Bull"}, {"key": "1238_CR63", "first-page": "533", "volume-title": "Biostatistical analysis, (Section 24.6)", "author": "J Zar", "year": "1999", "unstructured": "Zar J (1999) Biostatistical analysis, 4th edn, (Section 24.6). Prentice-Hall, Upper Saddle River, NJ, pp 533\u2013538", "edition": "4"}, {"key": "1238_CR64", "doi-asserted-by": "crossref", "first-page": "1406", "DOI": "10.1021/jm00036a003", "volume": "37", "author": "ZP Zhuang", "year": "1994", "unstructured": "Zhuang ZP, Kung MP, Kung HF (1994) Synthesis and evaluation of 4-(2'methoxyphenyl)-1-(2'-[N-(2\"-pyridinyl)-p-iodobenzamid]ethyl)piperazine (p-MPPI): a new radioiodinated 5-HT1A ligand. J Med Chem 37:1406\u20131407", "journal-title": "J Med Chem"}], "container-title": ["Psychopharmacology"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s00213-008-1238-0.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s00213-008-1238-0/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s00213-008-1238-0", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 23]], "date-time": "2019-05-23T20:06:43Z", "timestamp": 1558642003000}, "score": 53.557583, "issued": {"date-parts": [[2008, 7, 6]]}, "references-count": 64, "journal-issue": {"published-print": {"date-parts": [[2009, 4]]}, "issue": "2"}, "alternative-id": ["1238"], "URL": "http://dx.doi.org/10.1007/s00213-008-1238-0", "relation": {"cites": []}, "ISSN": ["0033-3158", "1432-2072"], "issn-type": [{"value": "0033-3158", "type": "print"}, {"value": "1432-2072", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T19:04:06Z", "timestamp": 1574449446007}, "reference-count": 46, "publisher": "Elsevier BV", "issue": "18", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2010, 9, 1]], "date-time": "2010-09-01T00:00:00Z", "timestamp": 1283299200000}, "delay-in-days": 0, "content-version": "tdm"}], "funder": [{"name": "NIH", "award": ["MH42705 (DEN)", "MH60397 (VJW)"]}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Bioorganic & Medicinal Chemistry"], "published-print": {"date-parts": [[2010, 9]]}, "DOI": "10.1016/j.bmc.2010.07.052", "type": "journal-article", "created": {"date-parts": [[2010, 7, 28]], "date-time": "2010-07-28T12:53:05Z", "timestamp": 1280321585000}, "page": "6763-6770", "source": "Crossref", "is-referenced-by-count": 8, "title": ["Facile synthesis of octahydrobenzo[h]isoquinolines: Novel and highly potent D1 dopamine agonists"], "prefix": "10.1016", "volume": "18", "author": [{"given": "Lisa A.", "family": "Bonner", "sequence": "first", "affiliation": []}, {"given": "Benjamin R.", "family": "Chemel", "sequence": "additional", "affiliation": []}, {"given": "Val J.", "family": "Watts", "sequence": "additional", "affiliation": []}, {"given": "David E.", "family": "Nichols", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Bioorganic & Medicinal Chemistry"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0968089610007054?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0968089610007054?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 9]], "date-time": "2018-12-09T04:23:11Z", "timestamp": 1544329391000}, "score": 52.983963, "issued": {"date-parts": [[2010, 9]]}, "references-count": 46, "journal-issue": {"published-print": {"date-parts": [[2010, 9]]}, "issue": "18"}, "alternative-id": ["S0968089610007054"], "URL": "http://dx.doi.org/10.1016/j.bmc.2010.07.052", "ISSN": ["0968-0896"], "issn-type": [{"value": "0968-0896", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T19:57:03Z", "timestamp": 1574452623280}, "reference-count": 38, "publisher": "American Society for Pharmacology & Experimental Therapeutics (ASPET)", "issue": "5", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Mol Pharmacol"], "published-print": {"date-parts": [[2012, 5]]}, "DOI": "10.1124/mol.111.077339", "type": "journal-article", "created": {"date-parts": [[2012, 2, 15]], "date-time": "2012-02-15T06:00:24Z", "timestamp": 1329285624000}, "page": "729-738", "source": "Crossref", "is-referenced-by-count": 13, "title": ["Ligand-Specific Roles for Transmembrane 5 Serine Residues in the Binding and Efficacy of Dopamine D1 Receptor Catechol Agonists"], "prefix": "10.1124", "volume": "81", "author": [{"given": "Benjamin R.", "family": "Chemel", "sequence": "first", "affiliation": []}, {"given": "Lisa A.", "family": "Bonner", "sequence": "additional", "affiliation": []}, {"given": "Val J.", "family": "Watts", "sequence": "additional", "affiliation": []}, {"given": "David E.", "family": "Nichols", "sequence": "additional", "affiliation": []}], "member": "36", "published-online": {"date-parts": [[2012, 2, 14]]}, "reference": [{"key": "2019081413510041000_81.5.729.1", "DOI": "10.1007/s12031-007-9030-x", "doi-asserted-by": "publisher"}, {"key": "2019081413510041000_81.5.729.2", "DOI": "10.1016/0922-4106(90)90194-3", "doi-asserted-by": "publisher"}, {"key": "2019081413510041000_81.5.729.3", "DOI": "10.1016/0014-2999(93)90840-E", "doi-asserted-by": "publisher"}, {"key": "2019081413510041000_81.5.729.4", "DOI": "10.1016/0014-2999(96)00309-3", "doi-asserted-by": "publisher"}, {"key": "2019081413510041000_81.5.729.5", "DOI": "10.1002/cmdc.201100010", "doi-asserted-by": "publisher"}, {"key": "2019081413510041000_81.5.729.6", "DOI": "10.1124/mol.56.5.989", "doi-asserted-by": "publisher"}, {"key": "2019081413510041000_81.5.729.7", "DOI": "10.1007/s00213-006-0490-4", "doi-asserted-by": "publisher"}, {"key": "2019081413510041000_81.5.729.8", "DOI": "10.1016/0006-2952(73)90196-2", "doi-asserted-by": "publisher"}, {"key": "2019081413510041000_81.5.729.9", "DOI": "10.1146/annurev.pa.33.040193.001433", "doi-asserted-by": "publisher"}, {"key": "2019081413510041000_81.5.729.10", "DOI": "10.1002/syn.890010408", "doi-asserted-by": "publisher"}, {"key": "2019081413510041000_81.5.729.11", "DOI": "10.1021/jm00112a034", "doi-asserted-by": "publisher"}, {"key": "2019081413510041000_81.5.729.12", "DOI": "10.1021/bi00405a027", "doi-asserted-by": "publisher"}, {"key": "2019081413510041000_81.5.729.13", "DOI": "10.1021/bi00393a013", "doi-asserted-by": "publisher"}, {"key": "2019081413510041000_81.5.729.14", "DOI": "10.1021/jm950707+", "doi-asserted-by": "publisher"}, {"key": "2019081413510041000_81.5.729.15", "doi-asserted-by": "crossref", "first-page": "1403", "DOI": "10.1016/j.bmc.2004.01.008", "article-title": "8,9-Dihydroxy-1,2,3,11b-tetrahydrochromeno[4,3,2,-de]isoquinoline (dinoxyline), a high affinity and potent agonist at all dopamine receptor isoforms", "volume": "12", "author": "Grubbs", "year": "2004", "journal-title": "Bioorg Med Chem"}, {"key": "2019081413510041000_81.5.729.16", "first-page": "532.9", "article-title": "Molecular and pharmacological characterization of D1-like dopamine receptors reveals structural requirements for critical amino acid residues (Abstract)", "volume": "27", "author": "Jassen", "year": "2000", "journal-title": "Soc Neurosci Abstr"}, {"key": "2019081413510041000_81.5.729.17", "DOI": "10.1016/0014-2999(92)90556-J", "doi-asserted-by": "publisher"}, {"key": "2019081413510041000_81.5.729.18", "DOI": "10.2174/187152706784111560", "doi-asserted-by": "publisher"}, {"key": "2019081413510041000_81.5.729.19", "first-page": "30299", "article-title": "Chimeric D1/D2 dopamine receptors. Distinct determinants of selective efficacy, potency, and signal transduction", "volume": "269", "author": "Kozell", "year": "1994", "journal-title": "J Biol Chem"}, {"key": "2019081413510041000_81.5.729.20", "DOI": "10.2174/187152706777452245", "doi-asserted-by": "publisher"}, {"key": "2019081413510041000_81.5.729.21", "DOI": "10.1074/jbc.M002092200", "doi-asserted-by": "publisher"}, {"key": "2019081413510041000_81.5.729.22", "DOI": "10.1111/j.1471-4159.1988.tb01051.x", "doi-asserted-by": "publisher"}, {"key": "2019081413510041000_81.5.729.23", "doi-asserted-by": "crossref", "first-page": "189", "DOI": "10.1152/physrev.1998.78.1.189", "article-title": "Dopamine receptors: from structure to function", "volume": "78", "author": "Missale", "year": "1998", "journal-title": "Physiol Rev"}, {"key": "2019081413510041000_81.5.729.24", "DOI": "10.1081/RRS-200029981", "doi-asserted-by": "publisher"}, {"key": "2019081413510041000_81.5.729.25", "unstructured": "Nichols DE (2010) Dopamine receptor subtype-selective drugs: D1-like receptors, in The Dopamine Receptors, 2nd ed ( Neve KA ed) Humana Press, New York.", "DOI": "10.1007/978-1-60327-333-6_4", "doi-asserted-by": "crossref"}, {"key": "2019081413510041000_81.5.729.26", "DOI": "10.1074/jbc.M504562200", "doi-asserted-by": "publisher"}, {"key": "2019081413510041000_81.5.729.27", "first-page": "17780", "article-title": "Serine mutations in transmembrane V of the dopamine D1 receptor affect ligand interactions and receptor activation", "volume": "267", "author": "Pollock", "year": "1992", "journal-title": "J Biol Chem"}, {"key": "2019081413510041000_81.5.729.28", "DOI": "10.1016/j.euroneuro.2008.10.002", "doi-asserted-by": "publisher"}, {"key": "2019081413510041000_81.5.729.29", "DOI": "10.1016/j.neuropharm.2006.08.028", "doi-asserted-by": "publisher"}, {"key": "2019081413510041000_81.5.729.30", "first-page": "13572", "article-title": "Identification of two serine residues involved in agonist activation of the beta-adrenergic receptor", "volume": "264", "author": "Strader", "year": "1989", "journal-title": "J Biol Chem"}, {"key": "2019081413510041000_81.5.729.31", "first-page": "10267", "article-title": "Conserved aspartic acid residues 79 and 113 of the \u03b2-adrenergic receptor have different roles in receptor function", "volume": "263", "author": "Strader", "year": "1988", "journal-title": "J Biol Chem"}, {"key": "2019081413510041000_81.5.729.32", "DOI": "10.1074/jbc.M310888200", "doi-asserted-by": "publisher"}, {"key": "2019081413510041000_81.5.729.33", "first-page": "27925", "article-title": "High agonist-independent activity is a distinguishing feature of the dopamine D1B receptor subtype", "volume": "269", "author": "Tiberi", "year": "1994", "journal-title": "J Biol Chem"}, {"key": "2019081413510041000_81.5.729.34", "DOI": "10.1006/bbrc.1993.1319", "doi-asserted-by": "publisher"}, {"key": "2019081413510041000_81.5.729.35", "first-page": "168", "article-title": "Site-directed mutagenesis of \u03b12A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists", "volume": "40", "author": "Wang", "year": "1991", "journal-title": "Mol Pharmacol"}, {"key": "2019081413510041000_81.5.729.36", "DOI": "10.1002/syn.890210211", "doi-asserted-by": "publisher"}, {"key": "2019081413510041000_81.5.729.37", "first-page": "966", "article-title": "Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors", "volume": "50", "author": "Watts", "year": "1996", "journal-title": "Mol Pharmacol"}, {"key": "2019081413510041000_81.5.729.38", "DOI": "10.1002/med.20130", "doi-asserted-by": "publisher"}], "container-title": ["Molecular Pharmacology"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1124/mol.111.077339", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 8, 14]], "date-time": "2019-08-14T20:53:55Z", "timestamp": 1565816035000}, "score": 48.502346, "issued": {"date-parts": [[2012, 2, 14]]}, "references-count": 38, "journal-issue": {"published-online": {"date-parts": [[2012, 4, 16]]}, "published-print": {"date-parts": [[2012, 5]]}, "issue": "5"}, "alternative-id": ["10.1124/mol.111.077339"], "URL": "http://dx.doi.org/10.1124/mol.111.077339", "relation": {"cites": []}, "ISSN": ["0026-895X", "1521-0111"], "issn-type": [{"value": "0026-895X", "type": "print"}, {"value": "1521-0111", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T08:13:16Z", "timestamp": 1574237596155}, "reference-count": 0, "publisher": "American Chemical Society (ACS)", "issue": "23", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J. Med. Chem."], "published-print": {"date-parts": [[2006, 11]]}, "DOI": "10.1021/jm0604979", "type": "journal-article", "created": {"date-parts": [[2006, 10, 17]], "date-time": "2006-10-17T16:02:55Z", "timestamp": 1161100975000}, "page": "6848-6857", "source": "Crossref", "is-referenced-by-count": 36, "title": ["trans-2,3-Dihydroxy-6a,7,8,12b-tetrahydro-6H-chromeno[3,4-c]isoquinoline:\u00a0 Synthesis, Resolution, and Preliminary Pharmacological Characterization of a New Dopamine D1Receptor Full Agonist"], "prefix": "10.1021", "volume": "49", "author": [{"given": "Juan Pablo", "family": "Cueva", "sequence": "first", "affiliation": []}, {"given": "Gianfabio", "family": "Giorgioni", "sequence": "additional", "affiliation": []}, {"given": "Russell A.", "family": "Grubbs", "sequence": "additional", "affiliation": []}, {"given": "Benjamin R.", "family": "Chemel", "sequence": "additional", "affiliation": []}, {"given": "Val J.", "family": "Watts", "sequence": "additional", "affiliation": []}, {"given": "David E.", "family": "Nichols", "sequence": "additional", "affiliation": []}], "member": "316", "container-title": ["Journal of Medicinal Chemistry"], "language": "en", "link": [{"URL": "https://pubs.acs.org/doi/pdf/10.1021/jm0604979", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 30]], "date-time": "2019-09-30T02:41:32Z", "timestamp": 1569811292000}, "score": 44.36514, "issued": {"date-parts": [[2006, 11]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2006, 11]]}, "issue": "23"}, "alternative-id": ["10.1021/jm0604979"], "URL": "http://dx.doi.org/10.1021/jm0604979", "ISSN": ["0022-2623", "1520-4804"], "issn-type": [{"value": "0022-2623", "type": "print"}, {"value": "1520-4804", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T15:11:27Z", "timestamp": 1574262687728}, "reference-count": 42, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2009, 2, 1]], "date-time": "2009-02-01T00:00:00Z", "timestamp": 1233446400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Neuropsychopharmacology"], "published-print": {"date-parts": [[2009, 2]]}, "DOI": "10.1016/j.euroneuro.2008.10.002", "type": "journal-article", "created": {"date-parts": [[2008, 11, 23]], "date-time": "2008-11-23T09:30:53Z", "timestamp": 1227432653000}, "page": "138-146", "source": "Crossref", "is-referenced-by-count": 12, "title": ["Comparison of the enantiomers of (\u00b1)-doxanthrine, a high efficacy full dopamine D1 receptor agonist, and a reversal of enantioselectivity at D1 versus alpha2C adrenergic receptors"], "prefix": "10.1016", "volume": "19", "author": [{"given": "Julie A.", "family": "Przybyla", "sequence": "first", "affiliation": []}, {"given": "Juan P.", "family": "Cueva", "sequence": "additional", "affiliation": []}, {"given": "Benjamin R.", "family": "Chemel", "sequence": "additional", "affiliation": []}, {"given": "K. Joseph", "family": "Hsu", "sequence": "additional", "affiliation": []}, {"suffix": "II", "given": "David J.", "family": "Riese", "sequence": "additional", "affiliation": []}, {"given": "John D.", "family": "McCorvy", "sequence": "additional", "affiliation": []}, {"given": "Julia A.", "family": "Chester", "sequence": "additional", "affiliation": []}, {"given": "David E.", "family": "Nichols", "sequence": "additional", "affiliation": []}, {"given": "Val J.", "family": "Watts", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Neuropsychopharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0924977X08002708?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0924977X08002708?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 5, 15]], "date-time": "2019-05-15T17:49:01Z", "timestamp": 1557942541000}, "score": 43.813343, "issued": {"date-parts": [[2009, 2]]}, "references-count": 42, "journal-issue": {"published-print": {"date-parts": [[2009, 2]]}, "issue": "2"}, "alternative-id": ["S0924977X08002708"], "URL": "http://dx.doi.org/10.1016/j.euroneuro.2008.10.002", "ISSN": ["0924-977X"], "issn-type": [{"value": "0924-977X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T14:08:12Z", "timestamp": 1574431692293}, "reference-count": 32, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2012, 2, 1]], "date-time": "2012-02-01T00:00:00Z", "timestamp": 1328054400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Journal of Medicinal Chemistry"], "published-print": {"date-parts": [[2012, 2]]}, "DOI": "10.1016/j.ejmech.2011.11.039", "type": "journal-article", "created": {"date-parts": [[2011, 12, 8]], "date-time": "2011-12-08T19:28:06Z", "timestamp": 1323372486000}, "page": "97-107", "source": "Crossref", "is-referenced-by-count": 5, "title": ["Analogues of doxanthrine reveal differences between the dopamine D1 receptor binding properties of chromanoisoquinolines and hexahydrobenzo[a]phenanthridines"], "prefix": "10.1016", "volume": "48", "author": [{"given": "Juan Pablo", "family": "Cueva", "sequence": "first", "affiliation": []}, {"given": "Benjamin R.", "family": "Chemel", "sequence": "additional", "affiliation": []}, {"suffix": "Jr.", "given": "Jose I.", "family": "Juncosa", "sequence": "additional", "affiliation": []}, {"given": "Markus A.", "family": "Lill", "sequence": "additional", "affiliation": []}, {"given": "Val J.", "family": "Watts", "sequence": "additional", "affiliation": []}, {"given": "David E.", "family": "Nichols", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Journal of Medicinal Chemistry"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0223523411008610?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0223523411008610?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 11, 28]], "date-time": "2018-11-28T02:56:24Z", "timestamp": 1543373784000}, "score": 42.551624, "issued": {"date-parts": [[2012, 2]]}, "references-count": 32, "alternative-id": ["S0223523411008610"], "URL": "http://dx.doi.org/10.1016/j.ejmech.2011.11.039", "ISSN": ["0223-5234"], "issn-type": [{"value": "0223-5234", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T11:46:29Z", "timestamp": 1574509589284}, "reference-count": 82, "publisher": "Wiley", "issue": "6", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 1587, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["ChemMedChem"], "published-print": {"date-parts": [[2011, 6, 6]]}, "DOI": "10.1002/cmdc.201100010", "type": "journal-article", "created": {"date-parts": [[2011, 4, 28]], "date-time": "2011-04-28T15:25:52Z", "timestamp": 1304004352000}, "page": "1024-1040", "source": "Crossref", "is-referenced-by-count": 14, "title": ["Mapping the Catechol Binding Site in Dopamine D1 Receptors: Synthesis and Evaluation of Two Parallel Series of Bicyclic Dopamine Analogues"], "prefix": "10.1002", "volume": "6", "author": [{"given": "Lisa A.", "family": "Bonner", "sequence": "first", "affiliation": []}, {"given": "Uros", "family": "Laban", "sequence": "additional", "affiliation": []}, {"given": "Benjamin R.", "family": "Chemel", "sequence": "additional", "affiliation": []}, {"given": "Jose I.", "family": "Juncosa", "sequence": "additional", "affiliation": []}, {"given": "Markus A.", "family": "Lill", "sequence": "additional", "affiliation": []}, {"given": "Val J.", "family": "Watts", "sequence": "additional", "affiliation": []}, {"given": "David E.", "family": "Nichols", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2011, 4, 28]]}, "reference": [{"key": "10.1002/cmdc.201100010-BIB1|cit1", "author": "Tarazi", "first-page": "3", "year": "2001", "journal-title": "SQU Journal for Scientific Research: Medical Sciences"}, {"key": "10.1002/cmdc.201100010-BIB2|cit2", "author": "Zhang", "volume": "107", "first-page": "274", "year": "2007", "journal-title": "Chem. Rev.", "DOI": "10.1021/cr050263h", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB3|cit3", "author": "Odowd", "volume": "60", "first-page": "804", "year": "1993", "journal-title": "J. Neurochem.", "DOI": "10.1111/j.1471-4159.1993.tb03224.x", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB4|cit4", "author": "Kebabian", "volume": "277", "first-page": "93", "year": "1979", "journal-title": "Nature", "DOI": "10.1038/277093a0", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB5|cit5", "author": "Kalani", "volume": "101", "first-page": "3815", "year": "2004", "journal-title": "Proc. Natl. Acad. Sci. USA", "DOI": "10.1073/pnas.0400100101", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB6|cit6", "author": "Shi", "volume": "42", "first-page": "437", "year": "2002", "journal-title": "Annu. Rev. Pharmacol. Toxicol.", "DOI": "10.1146/annurev.pharmtox.42.091101.144224", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB7|cit7", "author": "Tomic", "volume": "191", "first-page": "1020", "year": "1993", "journal-title": "Biochem. Biophys. Res. Commun.", "DOI": "10.1006/bbrc.1993.1319", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB8|cit8", "unstructured": "2008"}, {"key": "10.1002/cmdc.201100010-BIB9|cit9", "author": "Huang", "volume": "48", "first-page": "65", "year": "2001", "journal-title": "Int. Rev. Neurobiol.", "DOI": "10.1016/S0074-7742(01)48014-7", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB10|cit10", "author": "Neve", "year": "1996", "volume-title": "The Dopamine Receptors"}, {"key": "10.1002/cmdc.201100010-BIB11|cit11", "author": "Kaiser", "volume": "25", "first-page": "697", "year": "1982", "journal-title": "J. Med. Chem.", "DOI": "10.1021/jm00348a017", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB12|cit12", "author": "Jacob", "volume": "24", "first-page": "1013", "year": "1981", "journal-title": "J. Med. Chem.", "DOI": "10.1021/jm00140a021", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB13|cit13", "author": "Brewster", "volume": "33", "first-page": "1756", "year": "1990", "journal-title": "J. Med. Chem.", "DOI": "10.1021/jm00168a034", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB14|cit14", "author": "DeNinno", "volume": "34", "first-page": "2561", "year": "1991", "journal-title": "J. Med. Chem.", "DOI": "10.1021/jm00112a034", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB15|cit15", "author": "Michaelides", "volume": "34", "first-page": "2946", "year": "1991", "journal-title": "J. Med. Chem.", "DOI": "10.1021/jm00114a002", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB16|cit16", "author": "Est\u00e1cio", "volume": "108", "first-page": "10834", "year": "2004", "journal-title": "J. Phys. Chem. A", "DOI": "10.1021/jp0473422", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB17|cit17", "author": "Varfolomeev", "volume": "114", "first-page": "16503", "year": "2010", "journal-title": "J. Phys. Chem. B", "DOI": "10.1021/jp108459r", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB18|cit18", "author": "Boduszek", "volume": "30", "first-page": "1749", "year": "2000", "journal-title": "Synth. Commun.", "DOI": "10.1080/00397910008087219", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB19|cit19", "author": "Xu", "volume": "37", "first-page": "113", "year": "2002", "journal-title": "Yaoxue. Xuebao."}, {"key": "10.1002/cmdc.201100010-BIB20|cit20", "author": "Liu", "volume": "55", "first-page": "3803", "year": "1999", "journal-title": "Tetrahedron", "DOI": "10.1016/S0040-4020(99)00114-3", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB21|cit21", "author": "Pine", "volume": "50", "first-page": "1212", "year": "1985", "journal-title": "J. Org. Chem.", "DOI": "10.1021/jo00208a013", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB22|cit22", "author": "Kraus", "volume": "46", "first-page": "2417", "year": "1981", "journal-title": "J. Org. Chem.", "DOI": "10.1021/jo00324a050", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB23|cit23", "author": "Doodeman", "volume": "41", "first-page": "5979", "year": "2000", "journal-title": "Tetrahedron Lett.", "DOI": "10.1016/S0040-4039(00)00955-2", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB24|cit24", "author": "Ku", "volume": "68", "first-page": "3238", "year": "2003", "journal-title": "J. Org. Chem.", "DOI": "10.1021/jo0268613", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB25|cit25", "author": "Cohen", "volume": "54", "first-page": "3282", "year": "1989", "journal-title": "J. Org. Chem.", "DOI": "10.1021/jo00275a010", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB26|cit26", "author": "Miki", "volume": "38", "first-page": "3257", "year": "1990", "journal-title": "Chem. Pharm. Bull. (Tokyo)", "DOI": "10.1248/cpb.38.3257", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB27|cit27", "author": "Ku", "volume": "124", "first-page": "4282", "year": "2002", "journal-title": "J. Am. Chem. Soc.", "DOI": "10.1021/ja0171198", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB28|cit28", "author": "Bernotas", "volume": "20", "first-page": "1209", "year": "1990", "journal-title": "Synth. Commun.", "DOI": "10.1080/00397919008052829", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB29|cit29", "author": "Brown", "volume": "99", "first-page": "169", "year": "1987", "journal-title": "Angew. Chem.", "DOI": "10.1002/ange.19870990304", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB29.2|cit30", "volume": "26", "first-page": "190", "year": "1987", "journal-title": "Angew. Chem. Int. Ed. Engl.", "DOI": "10.1002/anie.198701901", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB30|cit31", "author": "Ghosh", "volume": "39", "first-page": "947", "year": "1998", "journal-title": "Tetrahedron Lett.", "DOI": "10.1016/S0040-4039(97)10666-9", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB31|cit32", "author": "Sajiki", "volume": "36", "first-page": "3465", "year": "1995", "journal-title": "Tetrahedron Lett.", "DOI": "10.1016/0040-4039(95)00527-J", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB32|cit33", "author": "Sajiki", "volume": "54", "first-page": "13981", "year": "1998", "journal-title": "Tetrahedron", "DOI": "10.1016/S0040-4020(98)00882-5", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB33|cit34", "author": "Kasal", "volume": "37", "first-page": "6221", "year": "1996", "journal-title": "Tetrahedron Lett.", "DOI": "10.1016/0040-4039(96)01328-7", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB34|cit35", "unstructured": "R. W. Schoenleber J. W. Kebabian Y. C. Martin M. P. DeNinno R. J. Perner D. M. Stout C. N. Hsaio S. DiDomenico ,\u2005 Jr. J. F. DeBernardis F. Z. Basha M. D. Meyer B. De P. P. Erlich J. R. Campbell H. E. Morton L. Lijewski Dopamine Agonists 1996"}, {"key": "10.1002/cmdc.201100010-BIB35|cit36", "author": "DeBernardis", "volume": "28", "first-page": "1398", "year": "1985", "journal-title": "J. Med. Chem.", "DOI": "10.1021/jm00148a005", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB36|cit37", "author": "Stevens", "first-page": "185", "year": "1992", "journal-title": "J. Chem. Soc. Perkin Trans. 1", "DOI": "10.1039/p19920000185", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB37|cit38", "author": "DeBernardis", "volume": "29", "first-page": "463", "year": "1986", "journal-title": "J. Med. Chem.", "DOI": "10.1021/jm00154a006", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB38|cit39", "author": "Meyer", "volume": "40", "first-page": "1049", "year": "1997", "journal-title": "J. Med. Chem.", "DOI": "10.1021/jm960723m", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB39|cit40", "author": "Adachi", "volume": "55", "first-page": "1655", "year": "1982", "journal-title": "Bull. Chem. Soc. Jpn.", "DOI": "10.1246/bcsj.55.1655", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB40|cit41", "author": "Kasturi", "volume": "13", "first-page": "648", "year": "1975", "journal-title": "Indian J. Chem."}, {"key": "10.1002/cmdc.201100010-BIB41|cit42", "author": "Sperber", "volume": "70", "first-page": "3091", "year": "1948", "journal-title": "J. Am. Chem. Soc.", "DOI": "10.1021/ja01189a076", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB42|cit43", "author": "Jin", "volume": "119", "first-page": "5773", "year": "1997", "journal-title": "J. Am. Chem. Soc.", "DOI": "10.1021/ja970839n", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB43|cit44", "author": "Leete", "volume": "86", "first-page": "1224", "year": "1964", "journal-title": "J. Am. Chem. Soc.", "DOI": "10.1021/ja01060a053", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB44|cit45", "unstructured": "Abstracts of the Society of Neuroscience"}, {"key": "10.1002/cmdc.201100010-BIB45|cit46", "unstructured": "Abstracts of the Society of Neuroscience"}, {"key": "10.1002/cmdc.201100010-BIB46|cit47", "author": "Bonner", "volume": "18", "first-page": "6763", "year": "2010", "journal-title": "Bioorg. Med. Chem.", "DOI": "10.1016/j.bmc.2010.07.052", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB47|cit48", "author": "Nichols", "year": "2010", "volume-title": "The Dopamine Receptors"}, {"key": "10.1002/cmdc.201100010-BIB48|cit49", "author": "Ahmed", "volume": "58", "first-page": "173", "year": "2003", "journal-title": "Pharmazie"}, {"key": "10.1002/cmdc.201100010-BIB49|cit50", "author": "Sakai", "volume": "55", "first-page": "691", "year": "1935", "journal-title": "J. Pharm. Soc. Jpn.", "DOI": "10.1248/yakushi1881.55.7_691", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB50|cit51", "author": "Perkin", "volume": "105", "first-page": "2376", "year": "1914", "journal-title": "J. Chem. Soc. Trans.", "DOI": "10.1039/CT9140502376", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB51|cit52", "author": "Beetz", "volume": "25", "first-page": "714", "year": "1982", "journal-title": "J. Med. Chem.", "DOI": "10.1021/jm00348a020", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB52|cit53", "author": "Elmore", "first-page": "4425", "year": "1961", "journal-title": "J. Chem. Soc.", "DOI": "10.1039/jr9610004425", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB53|cit54", "author": "Wamser", "volume": "103", "first-page": "7232", "year": "1981", "journal-title": "J. Am. Chem. Soc.", "DOI": "10.1021/ja00414a032", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB54|cit55", "author": "Barton", "volume": "48", "first-page": "407", "year": "1995", "journal-title": "Aust. J. Chem.", "DOI": "10.1071/CH9950407", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB55|cit56", "author": "Hulme", "year": "1992", "volume-title": "Receptor-Ligand Interactions: A Practical Approach"}, {"key": "10.1002/cmdc.201100010-BIB56|cit57", "author": "Watts", "volume": "242", "first-page": "165", "year": "1993", "journal-title": "Eur. J. Pharmacol.", "DOI": "10.1016/0014-2999(93)90076-T", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB57|cit58", "unstructured": "2006"}, {"key": "10.1002/cmdc.201100010-BIB58|cit59", "author": "Humphrey", "volume": "14", "first-page": "33", "year": "1996", "journal-title": "J. Mol. Graphics", "DOI": "10.1016/0263-7855(96)00018-5", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB59|cit60", "author": "Cherezov", "volume": "318", "first-page": "1258", "year": "2007", "journal-title": "Science", "DOI": "10.1126/science.1150577", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB60|cit61", "author": "Hess", "volume": "4", "first-page": "435", "year": "2008", "journal-title": "J. Chem. Theory Comput.", "DOI": "10.1021/ct700301q", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB61|cit62", "author": "Wang", "volume": "25", "first-page": "247", "year": "2006", "journal-title": "J. Mol. Graphics Modell.", "DOI": "10.1016/j.jmgm.2005.12.005", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB62|cit63", "author": "Wang", "volume": "25", "first-page": "1157", "year": "2004", "journal-title": "J. Comput. Chem.", "DOI": "10.1002/jcc.20035", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB63|cit64", "author": "Kuyper", "volume": "95", "first-page": "6661", "year": "1991", "journal-title": "J. Phys. Chem.", "DOI": "10.1021/j100170a052", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB64|cit65", "unstructured": "2007"}, {"key": "10.1002/cmdc.201100010-BIB65|cit66", "author": "Bayly", "volume": "97", "first-page": "10269", "year": "1993", "journal-title": "J. Phys. Chem.", "DOI": "10.1021/j100142a004", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB66|cit67", "author": "Wang", "volume": "21", "first-page": "1049", "year": "2000", "journal-title": "J. Comput. Chem.", "DOI": "10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB67|cit68", "author": "Duan", "volume": "24", "first-page": "1999", "year": "2003", "journal-title": "J. Comput. Chem.", "DOI": "10.1002/jcc.10349", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB68|cit69", "author": "Berger", "volume": "72", "first-page": "2002", "year": "1997", "journal-title": "Biophys. J.", "DOI": "10.1016/S0006-3495(97)78845-3", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB69|cit70", "author": "Bussi", "volume": "126", "first-page": "014101", "year": "2007", "journal-title": "J. Chem. Phys.", "DOI": "10.1063/1.2408420", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB70|cit71", "author": "Parrinello", "volume": "52", "first-page": "7182", "year": "1981", "journal-title": "J. Appl. Phys.", "DOI": "10.1063/1.328693", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB71|cit72", "author": "Hess", "volume": "18", "first-page": "1463", "year": "1997", "journal-title": "J. Comput. Chem.", "DOI": "10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB72|cit73", "author": "Okada", "volume": "342", "first-page": "571", "year": "2004", "journal-title": "J. Mol. Biol.", "DOI": "10.1016/j.jmb.2004.07.044", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB73|cit74", "author": "Park", "volume": "454", "first-page": "183", "year": "2008", "journal-title": "Nature", "DOI": "10.1038/nature07063", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB74|cit75", "author": "Hurst", "volume": "285", "first-page": "17954", "year": "2010", "journal-title": "J. Biol. Chem.", "DOI": "10.1074/jbc.M109.041590", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB75|cit76", "author": "Fiser", "volume": "9", "first-page": "1753", "year": "2000", "journal-title": "Protein Sci.", "DOI": "10.1110/ps.9.9.1753", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB76|cit77", "author": "Sali", "volume": "234", "first-page": "779", "year": "1993", "journal-title": "J. Mol. Biol.", "DOI": "10.1006/jmbi.1993.1626", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB77|cit78", "author": "Wu", "volume": "30", "first-page": "35", "year": "2002", "journal-title": "Nucleic Acids Res.", "DOI": "10.1093/nar/30.1.35", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB78|cit79", "author": "Wu", "volume": "31", "first-page": "345", "year": "2003", "journal-title": "Nucleic Acids Res.", "DOI": "10.1093/nar/gkg040", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB79|cit80", "unstructured": "2009"}, {"key": "10.1002/cmdc.201100010-BIB80|cit81", "author": "Jones", "volume": "245", "first-page": "43", "year": "1995", "journal-title": "J. Mol. Biol.", "DOI": "10.1016/S0022-2836(95)80037-9", "doi-asserted-by": "crossref"}, {"key": "10.1002/cmdc.201100010-BIB81|cit82", "author": "Jones", "volume": "267", "first-page": "727", "year": "1997", "journal-title": "J. Mol. Biol.", "DOI": "10.1006/jmbi.1996.0897", "doi-asserted-by": "crossref"}], "container-title": ["ChemMedChem"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcmdc.201100010", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/cmdc.201100010", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 10]], "date-time": "2019-06-10T10:58:24Z", "timestamp": 1560164304000}, "score": 41.38896, "issued": {"date-parts": [[2011, 4, 28]]}, "references-count": 82, "journal-issue": {"published-print": {"date-parts": [[2011, 6, 6]]}, "issue": "6"}, "URL": "http://dx.doi.org/10.1002/cmdc.201100010", "relation": {"cites": []}, "ISSN": ["1860-7179"], "issn-type": [{"value": "1860-7179", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T07:09:07Z", "timestamp": 1574233747968}, "reference-count": 0, "publisher": "American Association for the Advancement of Science (AAAS)", "issue": "4411", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Science"], "published-print": {"date-parts": [[1979, 9, 14]]}, "DOI": "10.1126/science.382359", "type": "journal-article", "created": {"date-parts": [[2006, 10, 5]], "date-time": "2006-10-05T16:39:42Z", "timestamp": 1160066382000}, "page": "1151-1153", "source": "Crossref", "is-referenced-by-count": 64, "title": ["Pharmacologic effects in man of a potent, long-acting dopamine receptor agonist"], "prefix": "10.1126", "volume": "205", "author": [{"given": "L", "family": "Lemberger", "sequence": "first", "affiliation": []}, {"given": "R.", "family": "Crabtree", "sequence": "additional", "affiliation": []}], "member": "221", "container-title": ["Science"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1126/science.382359", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T19:45:41Z", "timestamp": 1482522341000}, "score": 37.02735, "issued": {"date-parts": [[1979, 9, 14]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1979, 9, 14]]}, "issue": "4411"}, "URL": "http://dx.doi.org/10.1126/science.382359", "ISSN": ["0036-8075", "1095-9203"], "issn-type": [{"value": "0036-8075", "type": "print"}, {"value": "1095-9203", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T16:48:17Z", "timestamp": 1574441297441}, "reference-count": 30, "publisher": "Springer Science and Business Media LLC", "issue": "1", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2012, 1, 6]], "date-time": "2012-01-06T00:00:00Z", "timestamp": 1325808000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Psychopharmacology"], "published-print": {"date-parts": [[2012, 7]]}, "DOI": "10.1007/s00213-011-2625-5", "type": "journal-article", "created": {"date-parts": [[2012, 1, 6]], "date-time": "2012-01-06T00:37:09Z", "timestamp": 1325810229000}, "page": "81-87", "source": "Crossref", "is-referenced-by-count": 3, "title": ["Comparison of the D1 dopamine full agonists, dihydrexidine and doxanthrine, in the 6-OHDA rat model of Parkinson's disease"], "prefix": "10.1007", "volume": "222", "author": [{"given": "John D.", "family": "McCorvy", "sequence": "first", "affiliation": []}, {"given": "Val J.", "family": "Watts", "sequence": "additional", "affiliation": []}, {"given": "David E.", "family": "Nichols", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2012, 1, 6]]}, "reference": [{"key": "2625_CR1", "doi-asserted-by": "crossref", "first-page": "167", "DOI": "10.1016/0014-2999(93)90840-E", "volume": "235", "author": "KE Asin", "year": "1993", "unstructured": "Asin KE, Wirtshafter D (1993) Effects of repeated dopamine D1 receptor stimulation on rotation and c-fos expression. Eur J Pharmacol 235:167\u2013168", "journal-title": "Eur J Pharmacol"}, {"key": "2625_CR2", "doi-asserted-by": "crossref", "first-page": "81", "DOI": "10.1586/14737175.6.1.81", "volume": "6", "author": "U Bonuccelli", "year": "2006", "unstructured": "Bonuccelli U, Pavese N (2006) Dopamine agonists in the treatment of Parkinson's disease. Expert Rev Neurother 6:81\u201389", "journal-title": "Expert Rev Neurother"}, {"key": "2625_CR3", "doi-asserted-by": "crossref", "first-page": "41", "DOI": "10.1007/BF01244638", "volume": "68", "author": "A Braun", "year": "1987", "unstructured": "Braun A, Fabbrini G, Mouradian MM, Serrati C, Barone P, Chase TN (1987) Selective D-1 dopamine receptor agonist treatment of Parkinson's disease. J Neural Transm 68:41\u201350", "journal-title": "J Neural Transm"}, {"key": "2625_CR4", "doi-asserted-by": "crossref", "first-page": "1756", "DOI": "10.1021/jm00168a034", "volume": "33", "author": "WK Brewster", "year": "1990", "unstructured": "Brewster WK, Nichols DE, Riggs RM, Mottola DM, Lovenberg TW, Lewis MH, Mailman RB (1990) Trans-10,11-dihydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine: a highly potent selective dopamine D1 full agonist. J Med Chem 33:1756\u20131764", "journal-title": "J Med Chem"}, {"key": "2625_CR5", "first-page": "798", "volume": "288", "author": "P Chopin", "year": "1999", "unstructured": "Chopin P, Colpaert FC, Marien M (1999) Effects of alpha-2 adrenoceptor agonists and antagonists on circling behavior in rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway. J Pharmacol Exp Ther 288:798\u2013804", "journal-title": "J Pharmacol Exp Ther"}, {"key": "2625_CR6", "doi-asserted-by": "crossref", "first-page": "6848", "DOI": "10.1021/jm0604979", "volume": "49", "author": "JP Cueva", "year": "2006", "unstructured": "Cueva JP, Giorgioni G, Grubbs RA, Chemel BR, Watts VJ, Nichols DE (2006) trans-2,3-dihydroxy-6a,7,8,12b-tetrahydro-6H-chromeno[3,4-c]isoquinoline: synthesis, resolution, and preliminary pharmacological characterization of a new dopamine D1 receptor full agonist. J Med Chem 49:6848\u20136857", "journal-title": "J Med Chem"}, {"key": "2625_CR7", "doi-asserted-by": "crossref", "first-page": "303", "DOI": "10.1006/exnr.2002.7891", "volume": "175", "author": "R Deumens", "year": "2002", "unstructured": "Deumens R, Blokland A, Prickaerts J (2002) Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp Neurol 175:303\u2013317", "journal-title": "Exp Neurol"}, {"key": "2625_CR8", "doi-asserted-by": "crossref", "first-page": "2498", "DOI": "10.1056/NEJMoa033447", "volume": "351", "author": "S Fahn", "year": "2004", "unstructured": "Fahn S, Oakes D, Shoulson I, Kieburtz K, Rudolph A, Lang A, Olanow CW, Tanner C, Marek K (2004) Levodopa and the progression of Parkinson's disease. N Engl J Med 351:2498\u20132508", "journal-title": "N Engl J Med"}, {"key": "2625_CR9", "doi-asserted-by": "crossref", "first-page": "138", "DOI": "10.1007/PL00007856", "volume": "249", "author": "T Foltynie", "year": "2002", "unstructured": "Foltynie T, Brayne C, Barker RA (2002) The heterogeneity of idiopathic Parkinson's disease. J Neurol 249:138\u2013145", "journal-title": "J Neurol"}, {"key": "2625_CR10", "doi-asserted-by": "crossref", "first-page": "919", "DOI": "10.1002/ana.22423", "volume": "69", "author": "MD Gottwald", "year": "2011", "unstructured": "Gottwald MD, Aminoff MJ (2011) Therapies for dopaminergic-induced dyskinesias in Parkinson disease. Ann Neurol 69:919\u2013927", "journal-title": "Ann Neurol"}, {"key": "2625_CR11", "first-page": "241", "volume": "5", "author": "P Hickey", "year": "2011", "unstructured": "Hickey P, Stacy M (2011) Available and emerging treatments for Parkinson's disease: a review. Drug Des Devel Ther 5:241\u2013254", "journal-title": "Drug Des Devel Ther"}, {"issue": "Suppl 2", "key": "2625_CR12", "first-page": "S16", "volume": "64", "author": "P Jenner", "year": "2008", "unstructured": "Jenner P (2008) Functional models of Parkinson's disease: a valuable tool in the development of novel therapies. Ann Neurol 64(Suppl 2):S16\u2013S29", "journal-title": "Ann Neurol"}, {"key": "2625_CR13", "doi-asserted-by": "crossref", "first-page": "617", "DOI": "10.1016/0091-3057(94)00424-H", "volume": "51", "author": "BJ Johnson", "year": "1995", "unstructured": "Johnson BJ, Peacock V, Schneider JS (1995) Dihydrexidine, a full D1 dopamine receptor agonist, induces rotational asymmetry in hemiparkinsonian monkeys. Pharmacol Biochem Behav 51:617\u2013622", "journal-title": "Pharmacol Biochem Behav"}, {"key": "2625_CR14", "doi-asserted-by": "crossref", "first-page": "203", "DOI": "10.1016/0014-2999(92)90556-J", "volume": "229", "author": "JW Kebabian", "year": "1992", "unstructured": "Kebabian JW, Britton DR, DeNinno MP, Perner R, Smith L, Jenner P, Schoenleber R, Williams M (1992) A-77636: a potent and selective dopamine D1 receptor agonist with antiparkinsonian activity in marmosets. Eur J Pharmacol 229:203\u2013209", "journal-title": "Eur J Pharmacol"}, {"key": "2625_CR15", "doi-asserted-by": "crossref", "first-page": "2505", "DOI": "10.1097/00001756-199512150-00015", "volume": "6", "author": "RA Lahti", "year": "1995", "unstructured": "Lahti RA, Roberts RC, Tamminga CA (1995) D2-family receptor distribution in human postmortem tissue: an autoradiographic study. Neuroreport 6:2505\u20132512", "journal-title": "Neuroreport"}, {"key": "2625_CR16", "doi-asserted-by": "crossref", "first-page": "6351", "DOI": "10.1523/JNEUROSCI.23-15-06351.2003", "volume": "23", "author": "SJ Lewis", "year": "2003", "unstructured": "Lewis SJ, Dove A, Robbins TW, Barker RA, Owen AM (2003) Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry. J Neurosci 23:6351\u20136356", "journal-title": "J Neurosci"}, {"key": "2625_CR17", "first-page": "1022", "volume": "276", "author": "CW Lin", "year": "1996", "unstructured": "Lin CW, Bianchi BR, Miller TR, Stashko MA, Wang SS, Curzon P, Bednarz L, Asin KE, Britton DR (1996) Persistent activation of the dopamine D1 receptor contributes to prolonged receptor desensitization: studies with A-77636. J Pharmacol Exp Ther 276:1022\u20131029", "journal-title": "J Pharmacol Exp Ther"}, {"key": "2625_CR18", "doi-asserted-by": "crossref", "first-page": "377", "DOI": "10.1038/nrd3430", "volume": "10", "author": "WG Meissner", "year": "2011", "unstructured": "Meissner WG, Frasier M, Gasser T, Goetz CG, Lozano A, Piccini P, Obeso JA, Rascol O, Schapira A, Voon V, Weiner DM, Tison F, Bezard E (2011) Priorities in Parkinson's disease research. Nat Rev Drug Discov 10:377\u2013393", "journal-title": "Nat Rev Drug Discov"}, {"key": "2625_CR19", "author": "G Paxinos", "year": "1998", "edition": "4", "unstructured": "Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates, 4th edn. Academic, San Diego", "volume-title": "The rat brain in stereotaxic coordinates"}, {"key": "2625_CR20", "doi-asserted-by": "crossref", "first-page": "941", "DOI": "10.2165/11537810-000000000-00000", "volume": "24", "author": "S Perez-Lloret", "year": "2010", "unstructured": "Perez-Lloret S, Rascol O (2010) Dopamine receptor agonists for the treatment of early or advanced Parkinson's disease. CNS Drugs 24:941\u2013968", "journal-title": "CNS Drugs"}, {"key": "2625_CR21", "doi-asserted-by": "crossref", "first-page": "138", "DOI": "10.1016/j.euroneuro.2008.10.002", "volume": "19", "author": "JA Przybyla", "year": "2009", "unstructured": "Przybyla JA, Cueva JP, Chemel BR, Hsu KJ, Riese DJ, McCorvy JD, Chester JA, Nichols DE, Watts VJ (2009) Comparison of the enantiomers of (+/\u2212)-doxanthrine, a high efficacy full dopamine D(1) receptor agonist, and a reversal of enantioselectivity at D(1) versus alpha(2C) adrenergic receptors. Eur Neuropsychopharmacol 19:138\u2013146", "journal-title": "Eur Neuropsychopharmacol"}, {"key": "2625_CR22", "doi-asserted-by": "crossref", "first-page": "983", "DOI": "10.1016/S0306-4522(99)00037-8", "volume": "92", "author": "M Riekkinen", "year": "1999", "unstructured": "Riekkinen M, Jakala P, Kejonen K, Riekkinen P Jr (1999) The alpha2 agonist, clonidine, improves spatial working performance in Parkinson's disease. Neuroscience 92:983\u2013989", "journal-title": "Neuroscience"}, {"key": "2625_CR23", "doi-asserted-by": "crossref", "first-page": "547", "DOI": "10.1016/0091-3057(85)90273-4", "volume": "22", "author": "M Robin", "year": "1985", "unstructured": "Robin M, Forler C, Palfreyman MG (1985) Effect of chronic apomorphine on the development of denervation supersensitivity. Pharmacol Biochem Behav 22:547\u2013551", "journal-title": "Pharmacol Biochem Behav"}, {"key": "2625_CR24", "doi-asserted-by": "crossref", "first-page": "1128", "DOI": "10.1016/S1474-4422(09)70293-5", "volume": "8", "author": "MC Rodriguez-Oroz", "year": "2009", "unstructured": "Rodriguez-Oroz MC, Jahanshahi M, Krack P, Litvan I, Macias R, Bezard E, Obeso JA (2009) Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms. Lancet Neurol 8:1128\u20131139", "journal-title": "Lancet Neurol"}, {"key": "2625_CR25", "doi-asserted-by": "crossref", "first-page": "214", "DOI": "10.1097/01.nrl.0000215782.78763.fa", "volume": "12", "author": "D Silver", "year": "2006", "unstructured": "Silver D (2006) Impact of functional age on the use of dopamine agonists in patients with Parkinson disease. Neurologist 12:214\u2013223", "journal-title": "Neurologist"}, {"key": "2625_CR26", "doi-asserted-by": "crossref", "first-page": "389", "DOI": "10.1016/0014-2999(91)90508-N", "volume": "199", "author": "JR Taylor", "year": "1991", "unstructured": "Taylor JR, Lawrence MS, Redmond DE Jr, Elsworth JD, Roth RH, Nichols DE, Mailman RB (1991) Dihydrexidine, a full dopamine D1 agonist, reduces MPTP-induced parkinsonism in monkeys. Eur J Pharmacol 199:389\u2013391", "journal-title": "Eur J Pharmacol"}, {"key": "2625_CR27", "doi-asserted-by": "crossref", "first-page": "140", "DOI": "10.1097/WNF.0b013e318176c505", "volume": "32", "author": "D Tompson", "year": "2009", "unstructured": "Tompson D, Oliver-Willwong R (2009) Pharmacokinetic and pharmacodynamic comparison of ropinirole 24-hour prolonged release and ropinirole immediate release in patients with Parkinson's disease. Clin Neuropharmacol 32:140\u2013148", "journal-title": "Clin Neuropharmacol"}, {"key": "2625_CR28", "first-page": "37", "volume": "2", "author": "U Ungerstedt", "year": "1976", "unstructured": "Ungerstedt U (1976) 6-Hydroxydopamine-induced degeneration of the nigrostriatal dopamine pathway: the turning syndrome. Pharmacol Ther B 2:37\u201340", "journal-title": "Pharmacol Ther B"}, {"key": "2625_CR29", "doi-asserted-by": "crossref", "first-page": "153", "DOI": "10.1111/j.1749-6632.1997.tb48626.x", "volume": "835", "author": "GF Wooten", "year": "1997", "unstructured": "Wooten GF (1997) Functional anatomical and behavioral consequences of dopamine receptor stimulation. Ann N Y Acad Sci 835:153\u2013156", "journal-title": "Ann N Y Acad Sci"}, {"key": "2625_CR30", "doi-asserted-by": "crossref", "first-page": "143", "DOI": "10.1016/0014-2999(96)00061-1", "volume": "301", "author": "T Yoshikawa", "year": "1996", "unstructured": "Yoshikawa T, Yoshida N, Hosoki K (1996) Involvement of dopamine D3 receptors in the area postrema in R(+)-7-OH-DPAT-induced emesis in the ferret. Eur J Pharmacol 301:143\u2013149", "journal-title": "Eur J Pharmacol"}], "container-title": ["Psychopharmacology"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s00213-011-2625-5.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s00213-011-2625-5/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s00213-011-2625-5", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 22]], "date-time": "2019-06-22T03:22:14Z", "timestamp": 1561173734000}, "score": 36.634686, "issued": {"date-parts": [[2012, 1, 6]]}, "references-count": 30, "journal-issue": {"published-print": {"date-parts": [[2012, 7]]}, "issue": "1"}, "alternative-id": ["2625"], "URL": "http://dx.doi.org/10.1007/s00213-011-2625-5", "relation": {"cites": []}, "ISSN": ["0033-3158", "1432-2072"], "issn-type": [{"value": "0033-3158", "type": "print"}, {"value": "1432-2072", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T17:43:19Z", "timestamp": 1575135799695}, "reference-count": 0, "publisher": "American Chemical Society (ACS)", "issue": "15", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J. Med. Chem."], "published-print": {"date-parts": [[1994, 7]]}, "DOI": "10.1021/jm00041a025", "type": "journal-article", "created": {"date-parts": [[2005, 3, 18]], "date-time": "2005-03-18T11:44:23Z", "timestamp": 1111146263000}, "page": "2453-2460", "source": "Crossref", "is-referenced-by-count": 29, "title": ["Dopaminergic Benzo[a]phenanthridines: Resolution and Pharmacological Evaluation of the Enantiomers of Dihydrexidine, the Full Efficacy D1 Dopamine Receptor Agonist"], "prefix": "10.1021", "volume": "37", "author": [{"given": "Timm A.", "family": "Knoerzer", "sequence": "first", "affiliation": []}, {"given": "David E.", "family": "Nichols", "sequence": "additional", "affiliation": []}, {"given": "William K.", "family": "Brewster", "sequence": "additional", "affiliation": []}, {"given": "Val J.", "family": "Watts", "sequence": "additional", "affiliation": []}, {"given": "David", "family": "Mottola", "sequence": "additional", "affiliation": []}, {"given": "Richard B.", "family": "Mailman", "sequence": "additional", "affiliation": []}], "member": "316", "container-title": ["Journal of Medicinal Chemistry"], "language": "en", "link": [{"URL": "https://pubs.acs.org/doi/pdf/10.1021/jm00041a025", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 10, 9]], "date-time": "2019-10-09T05:15:07Z", "timestamp": 1570598107000}, "score": 36.272972, "issued": {"date-parts": [[1994, 7]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1994, 7]]}, "issue": "15"}, "alternative-id": ["10.1021/jm00041a025"], "URL": "http://dx.doi.org/10.1021/jm00041a025", "ISSN": ["0022-2623", "1520-4804"], "issn-type": [{"value": "0022-2623", "type": "print"}, {"value": "1520-4804", "type": "electronic"}], "subject": ["Molecular Medicine", "Drug Discovery"]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T06:32:14Z", "timestamp": 1574145134251}, "reference-count": 13, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1993, 4, 1]], "date-time": "1993-04-01T00:00:00Z", "timestamp": 733622400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Journal of Pharmacology"], "published-print": {"date-parts": [[1993, 4]]}, "DOI": "10.1016/0014-2999(93)90816-z", "type": "journal-article", "created": {"date-parts": [[2002, 12, 14]], "date-time": "2002-12-14T05:19:26Z", "timestamp": 1039843166000}, "page": "31-35", "source": "Crossref", "is-referenced-by-count": 7, "title": ["Dihydrexidine: a new potent peripheral dopamine D1 receptor agonist"], "prefix": "10.1016", "volume": "235", "author": [{"given": "Jai D.", "family": "Kohli", "sequence": "first", "affiliation": []}, {"given": "Patrick T.", "family": "Horn", "sequence": "additional", "affiliation": []}, {"given": "Dana", "family": "Glock", "sequence": "additional", "affiliation": []}, {"given": "William K.", "family": "Brewster", "sequence": "additional", "affiliation": []}, {"given": "David E.", "family": "Nichols", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Journal of Pharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:001429999390816Z?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:001429999390816Z?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 2]], "date-time": "2019-04-02T08:54:41Z", "timestamp": 1554195281000}, "score": 36.10184, "issued": {"date-parts": [[1993, 4]]}, "references-count": 13, "journal-issue": {"published-print": {"date-parts": [[1993, 4]]}, "issue": "1"}, "alternative-id": ["001429999390816Z"], "URL": "http://dx.doi.org/10.1016/0014-2999(93)90816-z", "ISSN": ["0014-2999"], "issn-type": [{"value": "0014-2999", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T11:15:27Z", "timestamp": 1574334927992}, "publisher-location": "Totowa, NJ", "reference-count": 86, "publisher": "Humana Press", "isbn-type": [{"value": "9781603273329", "type": "print"}, {"value": "9781603273336", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2010]]}, "DOI": "10.1007/978-1-60327-333-6_4", "type": "book-chapter", "created": {"date-parts": [[2009, 11, 12]], "date-time": "2009-11-12T14:34:17Z", "timestamp": 1258036457000}, "page": "75-99", "source": "Crossref", "is-referenced-by-count": 3, "title": ["Dopamine Receptor Subtype-Selective Drugs: D1-Like Receptors"], "prefix": "10.1007", "author": [{"given": "David E.", "family": "Nichols", "sequence": "first", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2009, 9, 19]]}, "reference": [{"key": "4_CR1", "doi-asserted-by": "publisher", "first-page": "93", "DOI": "10.1038/277093a0", "volume": "277", "author": "JW Kebabian", "year": "1979", "unstructured": "Kebabian JW, Calne DB. Multiple receptors for dopamine. Nature 1979;277:93\u20136.", "journal-title": "Nature"}, {"key": "4_CR2", "doi-asserted-by": "publisher", "first-page": "125", "DOI": "10.1016/0306-4522(86)90010-2", "volume": "19", "author": "A Dubois", "year": "1986", "unstructured": "Dubois A, Savasta M, Curet O et al. Autoradiographic distribution of the D1 agonist [3H]SKF 38393, in the rat brain and spinal cord. Comparison with the distribution of D2 dopamine receptors. Neuroscience 1986;19:125\u201337.", "journal-title": "Neuroscience"}, {"key": "4_CR3", "doi-asserted-by": "publisher", "first-page": "291", "DOI": "10.1016/0006-8993(86)90749-3", "volume": "375", "author": "M Savasta", "year": "1986", "unstructured": "Savasta M, Dubois A, Scatton B. Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SCH 23390. Brain Res 1986;375:291\u2013301.", "journal-title": "Brain Res"}, {"issue": "1", "key": "4_CR4", "doi-asserted-by": "publisher", "first-page": "S23", "DOI": "10.1291/hypres.18.SupplementI_S23", "volume": "18", "author": "F Amenta", "year": "1995", "unstructured": "Amenta F, Ferrante F, Ricci A. Pharmacological characterisation and autoradiographic localisation of dopamine receptor subtypes in the cardiovascular system and in the kidney. Hypertens Res 1995;18(Suppl 1):S23\u2013S27.", "journal-title": "Hypertens Res"}, {"key": "4_CR5", "doi-asserted-by": "publisher", "first-page": "6723", "DOI": "10.1073/pnas.87.17.6723", "volume": "87", "author": "FJ Monsma Jr", "year": "1990", "unstructured": "Monsma FJ, Jr., Mahan LC, McVittie LD et al. Molecular cloning and expression of a D1 dopamine receptor linked to adenylyl cyclase activation. Proc Natl Acad Sci U S A 1990;87:6723\u20137.", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "4_CR6", "doi-asserted-by": "publisher", "first-page": "614", "DOI": "10.1038/350614a0", "volume": "350", "author": "RK Sunahara", "year": "1991", "unstructured": "Sunahara RK, Guan HC, O\u2018Dowd BF et al. Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1. Nature 1991;350:614\u20139.", "journal-title": "Nature"}, {"key": "4_CR7", "doi-asserted-by": "publisher", "first-page": "2799", "DOI": "10.1517/14656566.8.16.2799", "volume": "8", "author": "IU Haq", "year": "2007", "unstructured": "Haq IU, LeWitt PA, Fernandez HH. Apomorphine therapy in Parkinson\u2019s disease: a review. Expert Opin Pharmacother 2007;8:2799\u2013809.", "journal-title": "Expert Opin Pharmacother"}, {"key": "4_CR8", "doi-asserted-by": "publisher", "first-page": "380", "DOI": "10.1021/mp060012c", "volume": "3", "author": "JA Subramony", "year": "2006", "unstructured": "Subramony JA. Apomorphine in dopaminergic therapy. Mol Pharm 2006;3:380\u20135.", "journal-title": "Mol Pharm"}, {"key": "4_CR9", "doi-asserted-by": "publisher", "first-page": "127", "DOI": "10.1007/s00702-006-0560-0", "volume": "114", "author": "R Horowski", "year": "2007", "unstructured": "Horowski R. A history of dopamine agonists. From the physiology and pharmacology of dopamine to therapies for prolactinomas and Parkinson\u2019s disease \u2013 a subjective view. J Neural Transm 2007;114:127\u201334.", "journal-title": "J Neural Transm"}, {"key": "4_CR10", "doi-asserted-by": "publisher", "first-page": "977", "DOI": "10.1021/jm00311a014", "volume": "11", "author": "MV Koch", "year": "1968", "unstructured": "Koch MV, Cannon JG, Burkman AM. Centrally acting emetics. II. Norapomorphine and derivatives. J Med Chem 1968;11:977\u201381.", "journal-title": "J Med Chem"}, {"key": "4_CR11", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1016/0014-2999(78)90015-8", "volume": "52", "author": "MK Menon", "year": "1978", "unstructured": "Menon MK, Clark WG, Neumeyer JL. Comparison of the dopaminergic effects of apomorphine and (-)-N-n-propylnorapomorphine. Eur J Pharmacol 1978;52:1\u20139.", "journal-title": "Eur J Pharmacol"}, {"key": "4_CR12", "doi-asserted-by": "publisher", "first-page": "1013", "DOI": "10.1021/jm00140a021", "volume": "24", "author": "JN Jacob", "year": "1981", "unstructured": "Jacob JN, Nichols DE, Kohli JD et al. Dopamine agonist properties of N-alkyl-4-(3,4-dihydroxyphenyl)-1,2,3,4- tetrahydroisoquinolines. J Med Chem 1981;24:1013\u20135.", "journal-title": "J Med Chem"}, {"key": "4_CR13", "author": "DE Nichols", "first-page": "201", "year": "1983", "unstructured": "Nichols DE. The development of novel dopamine agonists. In: Kaiser C, Kebabian JW, editors. Dopamine Receptors. Washington, D.C.: American Chemical Society; 1983pp. 201\u2013218.", "volume-title": "Dopamine Receptors", "DOI": "10.1021/bk-1983-0224.ch009", "doi-asserted-by": "publisher"}, {"key": "4_CR14", "doi-asserted-by": "publisher", "first-page": "3503", "DOI": "10.1021/jm960189i", "volume": "39", "author": "MH Hedberg", "year": "1996", "unstructured": "Hedberg MH, Linnanen T, Jansen JM et al. 11-Substituted (R)-aporphines: synthesis, pharmacology, and modeling of D-2A and 5-HT1A receptor interactions. J Med Chem 1996;39:3503\u201313.", "journal-title": "J Med Chem"}, {"key": "4_CR15", "first-page": "1582", "volume": "2", "author": "R Mailman", "year": "2001", "unstructured": "Mailman R, Huang X, Nichols DE. Parkinson\u2019s disease and D1 dopamine receptors. Curr Opin Investig Drugs 2001;2:1582\u201391.", "journal-title": "Curr Opin Investig Drugs"}, {"key": "4_CR16", "doi-asserted-by": "publisher", "first-page": "19", "DOI": "10.1016/0014-2999(78)90057-2", "volume": "51", "author": "RG Pendleton", "year": "1978", "unstructured": "Pendleton RG, Samler L, Kaiser C et al. Studies on renal dopamine receptors with a new agonist. Eur J Pharmacol 1978;51:19\u201328.", "journal-title": "Eur J Pharmacol"}, {"key": "4_CR17", "doi-asserted-by": "publisher", "first-page": "419", "DOI": "10.1016/0014-2999(78)90148-6", "volume": "50", "author": "PE Setler", "year": "1978", "unstructured": "Setler PE, Sarau HM, Zirkle CL et al. The central effects of a novel dopamine agonist. Eur J Pharmacol 1978;50:419\u201330.", "journal-title": "Eur J Pharmacol"}, {"key": "4_CR18", "doi-asserted-by": "publisher", "first-page": "335", "DOI": "10.1016/0922-4106(90)90194-3", "volume": "188", "author": "PH Andersen", "year": "1990", "unstructured": "Andersen PH, Jansen JA. Dopamine receptor agonists: selectivity and dopamine D1 receptor efficacy. Eur J Pharmacol 1990;188:335\u201347.", "journal-title": "Eur J Pharmacol"}, {"key": "4_CR19", "doi-asserted-by": "publisher", "first-page": "697", "DOI": "10.1021/jm00348a017", "volume": "25", "author": "C Kaiser", "year": "1982", "unstructured": "Kaiser C, Dandridge PA, Garvey E et al. Absolute stereochemistry and dopaminergic activity of enantiomers of 2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine. J Med Chem 1982;25:697\u2013703.", "journal-title": "J Med Chem"}, {"key": "4_CR20", "doi-asserted-by": "publisher", "first-page": "41", "DOI": "10.1007/BF01244638", "volume": "68", "author": "A Braun", "year": "1987", "unstructured": "Braun A, Fabbrini G, Mouradian MM et al. Selective D-1 dopamine receptor agonist treatment of Parkinson\u2019s disease. J Neural Transm 1987;68:41\u201350.", "journal-title": "J Neural Transm"}, {"key": "4_CR21", "first-page": "645", "volume": "10", "author": "J Weinstock", "year": "1985", "unstructured": "Weinstock J, Hieble JP. The chemistry and pharmacology of 3-benzazepine derivatives. Drug Future 1985;10:645\u201397.", "journal-title": "Drug Future"}, {"key": "4_CR22", "doi-asserted-by": "publisher", "first-page": "1327", "DOI": "10.1016/0028-3908(83)90208-3", "volume": "22", "author": "AJ Cross", "year": "1983", "unstructured": "Cross AJ, Marshal RD, Johnson JA et al. Preferential inhibition of ligand binding to calf striatal dopamine D1 receptors by SCH 23390. Neuropharmacology 1983;22:1327\u20139.", "journal-title": "Neuropharmacology"}, {"key": "4_CR23", "first-page": "462", "volume": "226", "author": "LC Iorio", "year": "1983", "unstructured": "Iorio LC, Barnett A, Leitz FH et al. SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems. J Pharmacol Exp Ther 1983;226:462\u20138.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "4_CR24", "doi-asserted-by": "publisher", "first-page": "137", "DOI": "10.1016/S0014-2999(03)02008-9", "volume": "474", "author": "JL Neumeyer", "year": "2003", "unstructured": "Neumeyer JL, Kula NS, Bergman J et al. Receptor affinities of dopamine D1 receptor-selective novel phenylbenzazepines. Eur J Pharmacol 2003;474:137\u201340.", "journal-title": "Eur J Pharmacol"}, {"key": "4_CR25", "doi-asserted-by": "publisher", "first-page": "285", "DOI": "10.1021/jm9502100", "volume": "39", "author": "DM Mottola", "year": "1996", "unstructured": "Mottola DM, Laiter S, Watts VJ et al. Conformational analysis of D1 dopamine receptor agonists: pharmacophore assessment and receptor mapping. J Med Chem 1996;39:285\u201396.", "journal-title": "J Med Chem"}, {"key": "4_CR26", "doi-asserted-by": "publisher", "first-page": "1913", "DOI": "10.1021/jm00128a038", "volume": "32", "author": "JG Berger", "year": "1989", "unstructured": "Berger JG, Chang WK, Clader JW et al. Synthesis and receptor affinities of some conformationally restricted analogues of the dopamine D1 selective ligand (5R)-8-chloro-2,3,4,5- tetrahydro-3-methyl-5-phenyl- 1H-3-benzazepin-7-ol. J Med Chem 1989;32:1913\u201321.", "journal-title": "J Med Chem"}, {"key": "4_CR27", "doi-asserted-by": "publisher", "first-page": "2395", "DOI": "10.1021/jm00013a015", "volume": "38", "author": "SE Snyder", "year": "1995", "unstructured": "Snyder SE, Aviles-Garay FA, Chakraborti R et al. Synthesis and evaluation of 6,7-dihydroxy-2,3,4,8,9,13b-hexahydro-1H- benzo[6,7]cyclohepta[1,2,3-ef][3]benzazepine, 6,7-dihydroxy- 1,2,3,4,8,12b-hexahydroanthr[10,4a,4-cd]azepine, and 10-(aminomethyl)-9,10- dihydro-1,2-dihydroxyanthracene as conformationally restricted analogs of beta-phenyldopamine. J Med Chem 1995;38:2395\u2013409.", "journal-title": "J Med Chem"}, {"key": "4_CR28", "first-page": "625", "volume": "4", "author": "JL Kinney", "year": "1985", "unstructured": "Kinney JL. Nomifensine maleate \u2013 A new 2nd-generation antidepressant. Clin Pharm 1985;4:625\u201336.", "journal-title": "Clin Pharm"}, {"key": "4_CR29", "doi-asserted-by": "publisher", "first-page": "153", "DOI": "10.1007/BF00421073", "volume": "41", "author": "B Costall", "year": "1975", "unstructured": "Costall B, Kelly DM, Naylor RJ. Nomifensine: a potent dopaminergic agonist of antiparkinson potential. Psychopharmacologia 1975;41:153\u201364.", "journal-title": "Psychopharmacologia"}, {"key": "4_CR30", "doi-asserted-by": "publisher", "first-page": "225", "DOI": "10.1111/j.2042-7158.1980.tb12899.x", "volume": "32", "author": "JD Kohli", "year": "1980", "unstructured": "Kohli JD, Goldberg LI. Effects of 3\u2032,4\u2032-dihydroxynomifensine on the dopamine vascular receptor. J Pharm Pharmacol 1980;32:225\u20136.", "journal-title": "J Pharm Pharmacol"}, {"key": "4_CR31", "doi-asserted-by": "publisher", "first-page": "291", "DOI": "10.1016/0014-2999(87)90240-8", "volume": "137", "author": "PH Andersen", "year": "1987", "unstructured": "Andersen PH, Nielsen EB, Scheel-Kruger J et al. Thienopyridine derivatives identified as the first selective, full efficacy, dopamine D1 receptor agonists. Eur J Pharmacol 1987;137:291\u20132.", "journal-title": "Eur J Pharmacol"}, {"key": "4_CR32", "doi-asserted-by": "publisher", "first-page": "1454", "DOI": "10.1021/jm00391a029", "volume": "30", "author": "RM Riggs", "year": "1987", "unstructured": "Riggs RM, Nichols DE, Foreman MM et al. Specific dopamine D-1 and DA1 properties of 4-(mono- and - dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinoline and its tetrahydrothieno[2,3-c]pyridine analogue. J Med Chem 1987;30:1454\u20138.", "journal-title": "J Med Chem"}, {"key": "4_CR33", "doi-asserted-by": "publisher", "first-page": "28", "DOI": "10.1021/jm00367a006", "volume": "27", "author": "PA Dandridge", "year": "1984", "unstructured": "Dandridge PA, Kaiser C, Brenner M et al. Synthesis, resolution, absolute stereochemistry, and enantioselectivity of 3\u2032,4\u2032-dihydroxynomifensine. J Med Chem 1984;27:28\u201335.", "journal-title": "J Med Chem"}, {"key": "4_CR34", "doi-asserted-by": "publisher", "first-page": "28", "DOI": "10.1021/jm00367a006", "volume": "27", "author": "PA Dandridge", "year": "1984", "unstructured": "Dandridge PA, Kaiser C, Brenner M et al. Synthesis, resolution, absolute stereochemistry, and enantioselectivity of 3',4'-dihydroxynomifensine. J Med Chem 1984;27:28\u201335.", "journal-title": "J Med Chem"}, {"key": "4_CR35", "author": "JD McDermed", "first-page": "568", "year": "1978", "unstructured": "McDermed JD, Freeman HS, Ferris RM. Enantioselectivity in the binding of (+) and (-)-2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronapthalene and related agonists to dopamine receptors. In: Usdin E, Kopin IJ, Barchas J, editors. Catecholamines: Basic and Clinical Frontiers. New York: Pergamon Press; 1978\u00a0pp. 568\u2013570.", "volume-title": "Catecholamines: Basic and Clinical Frontiers"}, {"key": "4_CR36", "doi-asserted-by": "publisher", "first-page": "1914", "DOI": "10.1021/jm00393a039", "volume": "30", "author": "RM Riggs", "year": "1987", "unstructured": "Riggs RM, McKenzie AT, Byrn SR et al. Effect of beta-alkyl substitution on D-1 dopamine agonist activity: absolute configuration of beta-methyldopamine. J Med Chem 1987;30:1914\u20138.", "journal-title": "J Med Chem"}, {"key": "4_CR37", "doi-asserted-by": "publisher", "first-page": "111", "DOI": "10.1016/0014-2999(89)90690-0", "volume": "166", "author": "TW Lovenberg", "year": "1989", "unstructured": "Lovenberg TW, Brewster WK, Mottola DM et al. Dihydrexidine, a novel selective high potency full dopamine D-1 receptor agonist. Eur J Pharmacol 1989;166:111\u20133.", "journal-title": "Eur J Pharmacol"}, {"key": "4_CR38", "first-page": "A379", "volume": "3", "author": "DM Mottola", "year": "1989", "unstructured": "Mottola DM, Brewster WK, Bennet J et al. In vivo and in vitro actions of DHBP, a unique agonist for both D1 and D2 dopamine receptors. Faseb J 1989;3:A379.", "journal-title": "Faseb J"}, {"key": "4_CR39", "doi-asserted-by": "publisher", "first-page": "2453", "DOI": "10.1021/jm00041a025", "volume": "37", "author": "TA Knoerzer", "year": "1994", "unstructured": "Knoerzer TA, Nichols DE, Brewster WK et al. Dopaminergic benzo[a]phenanthridines: resolution and pharmacological evaluation of the enantiomers of dihydrexidine, the full efficacy D1 dopamine receptor agonist. J Med Chem 1994;37:2453\u201360.", "journal-title": "J Med Chem"}, {"key": "4_CR40", "doi-asserted-by": "publisher", "first-page": "389", "DOI": "10.1016/0014-2999(91)90508-N", "volume": "199", "author": "JR Taylor", "year": "1991", "unstructured": "Taylor JR, Lawrence MS, Redmond DE, Jr. et al. Dihydrexidine, a full dopamine D1 agonist, reduces MPTP-induced parkinsonism in monkeys. Eur J Pharmacol 1991;199:389\u201391.", "journal-title": "Eur J Pharmacol"}, {"key": "4_CR41", "first-page": "339", "volume": "21", "author": "PJ Blanchet", "year": "1998", "unstructured": "Blanchet PJ, Fang J, Gillespie M et al. Effects of the full dopamine D1 receptor agonist dihydrexidine in Parkinson\u2019s disease. Clin Neuropharmacol 1998;21:339\u201343.", "journal-title": "Clin Neuropharmacol"}, {"key": "4_CR42", "doi-asserted-by": "publisher", "first-page": "31", "DOI": "10.1016/0014-2999(93)90816-Z", "volume": "235", "author": "JD Kohli", "year": "1993", "unstructured": "Kohli JD, Horn PT, Glock D et al. Dihydrexidine: a new potent peripheral dopamine D1 receptor agonist. Eur J Pharmacol 1993;235:31\u20135.", "journal-title": "Eur J Pharmacol"}, {"key": "4_CR43", "first-page": "187", "volume": "5", "author": "KJ Darney Jr", "year": "1991", "unstructured": "Darney KJ, Jr., Lewis MH, Brewster WK et al. Behavioral effects in the rat of dihydrexidine, a high-potency, full-efficacy D1 dopamine receptor agonist. Neuropsychopharmacol 1991;5:187\u201395.", "journal-title": "Neuropsychopharmacol"}, {"key": "4_CR44", "doi-asserted-by": "publisher", "first-page": "L229", "DOI": "10.1016/0024-3205(91)90299-Q", "volume": "49", "author": "MS Lawrence", "year": "1991", "unstructured": "Lawrence MS, Redmond DE, Jr., Elsworth JD et al. The D1 receptor antagonist, SCH 23390, induces signs of parkinsonism in African green monkeys. Life Sci 1991;49:L229\u201334.", "journal-title": "Life Sci"}, {"key": "4_CR45", "doi-asserted-by": "publisher", "first-page": "318", "DOI": "10.1021/jm00002a013", "volume": "38", "author": "WK Brewster", "year": "1995", "unstructured": "Brewster WK, Nichols DE, Watts VJ et al. Evaluation of cis- and trans-9- and 11-hydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridines as structurally rigid, selective D1 dopamine receptor ligands. J Med Chem 1995;38:318\u201327.", "journal-title": "J Med Chem"}, {"key": "4_CR46", "doi-asserted-by": "publisher", "first-page": "1756", "DOI": "10.1021/jm00168a034", "volume": "33", "author": "WK Brewster", "year": "1990", "unstructured": "Brewster WK, Nichols DE, Riggs RM et al. trans-10,11-dihydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine: a highly potent selective dopamine D1 full agonist. J Med Chem 1990;33:1756\u201364.", "journal-title": "J Med Chem"}, {"key": "4_CR47", "doi-asserted-by": "publisher", "first-page": "2140", "DOI": "10.1021/jm970157a", "volume": "40", "author": "K Negash", "year": "1997", "unstructured": "Negash K, Nichols DE, Watts VJ et al. Further definition of the D1 dopamine receptor pharmacophore: synthesis of trans-6,6a,7,8,9,13b-hexahydro-5H-benzo[d]naphth[2,1-b]azepines as rigid analogues of beta-phenyldopamine. J Med Chem 1997;40:2140\u20137.", "journal-title": "J Med Chem"}, {"key": "4_CR48", "doi-asserted-by": "publisher", "first-page": "3062", "DOI": "10.1021/jm00016a009", "volume": "38", "author": "TA Knoerzer", "year": "1995", "unstructured": "Knoerzer TA, Watts VJ, Nichols DE et al. Synthesis and biological evaluation of a series of substituted benzo[a]phenanthridines as agonists at D1 and D2 dopamine receptors. J Med Chem 1995;38:3062\u201370.", "journal-title": "J Med Chem"}, {"key": "4_CR49", "doi-asserted-by": "publisher", "first-page": "3445", "DOI": "10.1021/jm00018a002", "volume": "38", "author": "MR Michaelides", "year": "1995", "unstructured": "Michaelides MR, Hong Y, DiDomenico SJ et al. (5aR,11bS)-4,5,5a,6,7,11b-hexahydro-2-propyl-3-thia-5-azacyclopent-1- ena[c]-phenanthrene-9,10-diol (A-86929): a potent and selective dopamine D1 agonist that maintains behavioral efficacy following repeated administration and characterization of its diacetyl prodrug (ABT-431). J Med Chem 1995;38:3445\u20137.", "journal-title": "J Med Chem"}, {"key": "4_CR50", "first-page": "150", "volume": "276", "author": "K Shiosaki", "year": "1996", "unstructured": "Shiosaki K, Jenner P, Asin KE et al. ABT-431: the diacetyl prodrug of A-86929, a potent and selective dopamine D1 receptor agonist: in vitro characterization and effects in animal models of Parkinson\u2019s disease. J Pharmacol Exp Ther 1996;276:150\u201360.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "4_CR51", "doi-asserted-by": "publisher", "first-page": "1585", "DOI": "10.1021/jm970038v", "volume": "40", "author": "MR Michaelides", "year": "1997", "unstructured": "Michaelides MR, Hong Y, Didomenico S et al. Substituted hexahydrobenzo[f]thieno[c]quinolines as dopamine D1- selective agonists: synthesis and biological evaluation in vitro and in vivo. J Med Chem 1997;40:1585\u201399.", "journal-title": "J Med Chem"}, {"key": "4_CR52", "doi-asserted-by": "publisher", "first-page": "736", "DOI": "10.1002/1531-8249(199906)45:6<736::AID-ANA7>3.0.CO;2-F", "volume": "45", "author": "O Rascol", "year": "1999", "unstructured": "Rascol O, Blin O, Thalamas C et al. ABT-431, a D1 receptor agonist prodrug, has efficacy in Parkinson\u2019s disease. Ann Neurol 1999;45:736\u201341.", "journal-title": "Ann Neurol"}, {"key": "4_CR53", "doi-asserted-by": "publisher", "first-page": "249", "DOI": "10.1001/archneur.58.2.249", "volume": "58", "author": "O Rascol", "year": "2001", "unstructured": "Rascol O, Nutt JG, Blin O et al. Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson disease. Arch Neurol 2001;58:249\u201354.", "journal-title": "Arch Neurol"}, {"key": "4_CR54", "doi-asserted-by": "publisher", "first-page": "2946", "DOI": "10.1021/jm00114a002", "volume": "34", "author": "MR Michaelides", "year": "1991", "unstructured": "Michaelides MR, Schoenleber R, Thomas S et al. Synthesis and pharmacological evaluation of 1-(aminomethyl)-3,4-dihydro- 5-hydroxy-1H-2-benzopyrans as dopamine D1 selective ligands. J Med Chem 1991;34:2946\u201353.", "journal-title": "J Med Chem"}, {"key": "4_CR55", "doi-asserted-by": "publisher", "first-page": "2948", "DOI": "10.1021/jm00173a005", "volume": "33", "author": "MP DeNinno", "year": "1990", "unstructured": "DeNinno MP, Schoenleber R, Asin KE et al. (1R,3S)-1-(aminomethyl)-3,4-dihydro-5,6-dihydroxy-3-phenyl-1H-2- benzopyran: a potent and selective D1 agonist. J Med Chem 1990;33:2948\u201350.", "journal-title": "J Med Chem"}, {"key": "4_CR56", "doi-asserted-by": "publisher", "first-page": "209", "DOI": "10.1016/0014-2999(91)90459-4", "volume": "199", "author": "MP DeNinno", "year": "1991", "unstructured": "DeNinno MP, Schoenleber R, MacKenzie R et al. A68930: a potent agonist selective for the dopamine D1 receptor. Eur J Pharmacol 1991;199:209\u201319.", "journal-title": "Eur J Pharmacol"}, {"key": "4_CR57", "doi-asserted-by": "publisher", "first-page": "2561", "DOI": "10.1021/jm00112a034", "volume": "34", "author": "MP DeNinno", "year": "1991", "unstructured": "DeNinno MP, Schoenleber R, Perner RJ et al. Synthesis and dopaminergic activity of 3-substituted 1-(aminomethyl)- 3,4-dihydro-5,6-dihydroxy-1H-2-benzopyrans: characterization of an auxiliary binding region in the D1 receptor. J Med Chem 1991;34:2561\u20139.", "journal-title": "J Med Chem"}, {"key": "4_CR58", "doi-asserted-by": "publisher", "first-page": "203", "DOI": "10.1016/0014-2999(92)90556-J", "volume": "229", "author": "JW Kebabian", "year": "1992", "unstructured": "Kebabian JW, Britton DR, DeNinno MP et al. A-77636: a potent and selective dopamine D1 receptor agonist with antiparkinsonian activity in marmosets. Eur J Pharmacol 1992;229: 203\u20139.", "journal-title": "Eur J Pharmacol"}, {"key": "4_CR59", "doi-asserted-by": "crossref", "first-page": "40S", "DOI": "10.1093/ajh/3.6.40S", "volume": "3", "author": "JW Kebabian", "year": "1990", "unstructured": "Kebabian JW, Briggs C, Britton DR et al. A68930: a potent and specific agonist for the D1 dopamine receptor. Am J Hypertens 1990;3:40S\u20132S.", "journal-title": "Am J Hypertens"}, {"key": "4_CR60", "doi-asserted-by": "publisher", "first-page": "157S", "DOI": "10.1016/0197-0186(92)90230-O", "volume": "20", "author": "JW Kebabian", "year": "1992", "unstructured": "Kebabian JW, DeNinno MP, Schoenleber R et al. A68930: a potent agonist specific for the dopamine D1 receptor. Neurochem Int 1992;20(Suppl):157S\u201360S.", "journal-title": "Neurochem Int"}, {"key": "4_CR61", "author": "U Laban", "year": "2004", "unstructured": "Laban U. Synthesis of 4-aminomethylchromans: novel dopamine D2-selective agonists. PhD thesis, Purdue University, West Lafayette, IN; 2004.", "volume-title": "Synthesis of 4-aminomethylchromans: novel dopamine D2-selective agonists"}, {"key": "4_CR62", "first-page": "351", "volume": "33", "author": "BR Chemel", "year": "2007", "unstructured": "Chemel BR, Bonner LA, Watts VJ et al. D1 versus D2 dopamine receptor selectivity is determined by intramolecular hydrogen bonding patterns in catechol-containing novel dopamine analogues. Soc Neurosci Abstr 2007;33:351.1.", "journal-title": "Soc Neurosci Abstr"}, {"key": "4_CR63", "doi-asserted-by": "publisher", "first-page": "549", "DOI": "10.1021/jm950707+", "volume": "39", "author": "D Ghosh", "year": "1996", "unstructured": "Ghosh D, Snyder SE, Watts VJ et al. 9-Dihydroxy-2,3,7,11b-tetrahydro-1H-naph[1,2,3-de]isoquinoline: a potent full dopamine D1 agonist containing a rigid-beta-phenyldopamine pharmacophore. J Med Chem 1996;39:549\u201355.", "journal-title": "J Med Chem"}, {"key": "4_CR64", "doi-asserted-by": "publisher", "first-page": "3660", "DOI": "10.1021/jm0101545", "volume": "45", "author": "SY Sit", "year": "2002", "unstructured": "Sit SY, Xie K, Jacutin-Porte S et al. (+)-Dinapsoline: An efficient synthesis and pharmacological profile of a novel dopamine agonist. J Med Chem 2002;45:3660\u20138.", "journal-title": "J Med Chem"}, {"key": "4_CR65", "first-page": "338", "volume": "296", "author": "AG Gulwadi", "year": "2001", "unstructured": "Gulwadi AG, Korpinen CD, Mailman RB et al. Dinapsoline: characterization of a D(1) dopamine receptor agonist in a rat model of Parkinson\u2019s disease. J Pharmacol Exp Ther 2001;296:338\u201344.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "4_CR66", "doi-asserted-by": "publisher", "first-page": "715", "DOI": "10.1016/j.bmc.2003.11.015", "volume": "12", "author": "SY Sit", "year": "2004", "unstructured": "Sit SY, Xie K, Jacutin-Porte S et al. Synthesis and SAR exploration of dinapsoline analogues. Bioorg Med Chem 2004;12:715\u201334.", "journal-title": "Bioorg Med Chem"}, {"key": "4_CR67", "author": "RA Grubbs", "year": "2000", "unstructured": "Grubbs RA. Synthesis of novel dopaminergic ligands: a bioisosteric approach. PhD thesis, Purdue University, West Lafayette, IN;2000.", "volume-title": "Synthesis of novel dopaminergic ligands: a bioisosteric approach"}, {"key": "4_CR68", "doi-asserted-by": "publisher", "first-page": "1403", "DOI": "10.1016/j.bmc.2004.01.008", "volume": "12", "author": "RA Grubbs", "year": "2004", "unstructured": "Grubbs RA, Lewis MM, Owens-Vance C et al. 8,9-Dihydroxy-1,2,3,11b-tetrahydrochromeno[4,3,2,-de]isoquinoline (dinoxyline), a high affinity and potent agonist at all dopamine receptor isoforms. Bioorg Med Chem 2004;12:1403\u201312.", "journal-title": "Bioorg Med Chem"}, {"key": "4_CR69", "doi-asserted-by": "publisher", "first-page": "6848", "DOI": "10.1021/jm0604979", "volume": "49", "author": "JP Cueva", "year": "2006", "unstructured": "Cueva JP, Giorgioni G, Grubbs RA et al. trans-2,3-Dihydroxy-6a,7,8,12b-tetrahydro-6H-chromeno[3,4-c]isoquinoline: Synthesis, resolution, and preliminary pharmacological characterization of a new dopamine D1 receptor full agonist. J Med Chem 2006;49:6848\u201357.", "journal-title": "J Med Chem"}, {"key": "4_CR70", "author": "JP Cueva", "year": "2008", "unstructured": "Cueva JP. Inquiry into the structural and conformational requirements of \u03b2-phenyldopamine-type ligands for selective dopamine D1 receptor activation. PhD thesis, Purdue University, West Lafayette, IN; 2008.", "volume-title": "Inquiry into the structural and conformational requirements of \u03b2-phenyldopamine-type ligands for selective dopamine D1 receptor activation"}, {"issue": "10", "key": "4_CR71", "doi-asserted-by": "publisher", "first-page": "1904", "DOI": "10.1021/jm00160a018", "volume": "29", "author": "DL Ladd", "year": "1986", "unstructured": "Ladd DL, Weinstock J, Wise M, Gessner GW, Sawyer JL, Flaim KE. Synthesis and dopaminergic binding of 2-aryldopamine analogues: phenethylamines, 3-benzazepines, and 9-(aminomethyl)fluorenes. J Med Chem 1986; 29(10):1904\u201312.", "journal-title": "J Med Chem"}, {"key": "4_CR72", "first-page": "177", "volume": "9", "author": "JG Cannon", "year": "1975", "unstructured": "Cannon JG. Chemistry of dopaminergic agonists. Adv Neurol 1975;9:177\u201383.", "journal-title": "Adv Neurol"}, {"key": "4_CR73", "doi-asserted-by": "publisher", "first-page": "36", "DOI": "10.1007/s008940050005", "volume": "1", "author": "M Froimowitz", "year": "1995", "unstructured": "Froimowitz M, Bellott EM, Jr. Structural factors that distinguish dopamine D1 and D1 agonists. J Mol Model 1995;1:36\u201345.", "journal-title": "J Mol Model"}, {"key": "4_CR74", "doi-asserted-by": "publisher", "first-page": "3553", "DOI": "10.1016/j.bmc.2004.04.029", "volume": "12", "author": "C Csutoras", "year": "2004", "unstructured": "Csutoras C, Zhang A, Zhang KH et al. Synthesis and neuropharmacological evaluation of R(-)-N-alkyl-11-hydroxynoraporphines and their esters. Bioorg Med Chem 2004;12:3553\u20139.", "journal-title": "Bioorg Med Chem"}, {"key": "4_CR75", "doi-asserted-by": "publisher", "first-page": "25", "DOI": "10.1021/jm00223a006", "volume": "19", "author": "JL Neumeyer", "year": "1976", "unstructured": "Neumeyer JL, Reinhard JF, Dafeldecker WP et al. Aporphines 14. Dopaminergic and antinociceptive activity of aporphine derivatives \u2013 synthesis of 10-hydroxyaporphines and 10-hydroxy-N-normal-propylnoraporphine. J Med Chem 1976;19:25\u20139.", "journal-title": "J Med Chem"}, {"key": "4_CR76", "doi-asserted-by": "publisher", "first-page": "303", "DOI": "10.1021/jm00105a047", "volume": "34", "author": "MP Seiler", "year": "1991", "unstructured": "Seiler MP, Hagenbach A, Wuthrich HJ et al. trans-hexahydroindolo[4,3-ab]phenanthridines (\u201cbenzergolines\u201d), the first structural class of potent and selective dopamine D1 receptor agonists lacking a catechol group. J Med Chem 1991;34:303\u20137.", "journal-title": "J Med Chem"}, {"key": "4_CR77", "doi-asserted-by": "publisher", "first-page": "167", "DOI": "10.1016/S0022-5193(76)80030-6", "volume": "59", "author": "DE Nichols", "year": "1976", "unstructured": "Nichols DE. Structural correlation between apomorphine and LSD: involvement of dopamine as well as serotonin in the actions of hallucinogens. J Theor Biol 1976;59:167\u201377.", "journal-title": "J Theor Biol"}, {"key": "4_CR78", "doi-asserted-by": "publisher", "first-page": "481", "DOI": "10.1021/jm00179a003", "volume": "23", "author": "NJ Bach", "year": "1980", "unstructured": "Bach NJ, Kornfeld EC, Jones ND et al. Bicyclic and tricyclic ergoline partial structures. Rigid 3-(2- aminoethyl)pyrroles and 3- and 4-(2-aminoethyl)pyrazoles as dopamine agonists. J Med Chem 1980;23:481\u201391.", "journal-title": "J Med Chem"}, {"key": "4_CR79", "doi-asserted-by": "publisher", "first-page": "780", "DOI": "10.1111/j.2042-7158.1983.tb02896.x", "volume": "35", "author": "D Kocjan", "year": "1983", "unstructured": "Kocjan D, Hadzi D. Conformationally restricted dopamine congeners\u2013a molecular mechanics-based study. J Pharm Pharmacol 1983;35:780\u20135.", "journal-title": "J Pharm Pharmacol"}, {"key": "4_CR80", "doi-asserted-by": "publisher", "first-page": "261", "DOI": "10.1002/mds.870040307", "volume": "4", "author": "JA Temlett", "year": "1989", "unstructured": "Temlett JA, Quinn NP, Jenner PG et al. Antiparkinsonian activity of CY 208-243, a partial D-1 dopamine receptor agonist, in MPTP-treated marmosets and patients with Parkinson\u2019s disease. Mov Disord 1989;4:261\u20135.", "journal-title": "Mov Disord"}, {"key": "4_CR81", "first-page": "17780", "volume": "267", "author": "NJ Pollock", "year": "1992", "unstructured": "Pollock NJ, Manelli AM, Hutchins CW et al. Serine mutations in transmembrane V of the dopamine D1 receptor affect ligand interactions and receptor activation. J Biol Chem 1992;267:17780\u20136.", "journal-title": "J Biol Chem"}, {"key": "4_CR82", "doi-asserted-by": "publisher", "first-page": "1020", "DOI": "10.1006/bbrc.1993.1319", "volume": "191", "author": "M Tomic", "year": "1993", "unstructured": "Tomic M, Seeman P, George SR et al. Dopamine D1 receptor mutagenesis: role of amino acids in agonist and antagonist binding. Biochem Biophys Res Commun 1993;191:1020\u20137.", "journal-title": "Biochem Biophys Res Commun"}, {"key": "4_CR83", "doi-asserted-by": "publisher", "first-page": "1258", "DOI": "10.1126/science.1150577", "volume": "318", "author": "V Cherezov", "year": "2007", "unstructured": "Cherezov V, Rosenbaum DM, Hanson MA et al. High-resolution crystal structure of an engineered human 2-Adrenergic G protein coupled receptor. Science 2007;318:1258\u201365.", "journal-title": "Science"}, {"key": "4_CR84", "first-page": "10267", "volume": "263", "author": "CD Strader", "year": "1988", "unstructured": "Strader CD, Sigal IS, Candelore MR et al. Conserved aspartic acid residues 79 and 113 of the beta-adrenergic receptor have different roles in receptor function. J Biol Chem 1988;263:10267\u201371.", "journal-title": "J Biol Chem"}, {"key": "4_CR85", "doi-asserted-by": "publisher", "first-page": "101", "DOI": "10.1146/annurev.bi.63.070194.000533", "volume": "63", "author": "CD Strader", "year": "1994", "unstructured": "Strader CD, Fong TM, Tota MR et al. Structure and function of G protein-coupled receptors. Ann Rev Biochem 1994;63:101\u201332.", "journal-title": "Ann Rev Biochem"}, {"key": "4_CR86", "first-page": "185", "volume": "69", "author": "H Lan", "year": "2006", "unstructured": "Lan H, Du R and CJ, Teeter MM, Neve KA. Structural determinants of pharmacological specificity between D1 and D2 dopamine receptors. Mol Pharmacol 2006;69:185\u201394.", "journal-title": "Mol Pharmacol"}], "container-title": ["The Dopamine Receptors"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-1-60327-333-6_4", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 10]], "date-time": "2019-03-10T19:05:13Z", "timestamp": 1552244713000}, "score": 36.038357, "issued": {"date-parts": [[2009, 9, 19]]}, "ISBN": ["9781603273329", "9781603273336"], "references-count": 86, "URL": "http://dx.doi.org/10.1007/978-1-60327-333-6_4", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T17:54:56Z", "timestamp": 1574531696617}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "5 and 6", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Behavioural Pharmacology"], "published-print": {"date-parts": [[2011, 9]]}, "DOI": "10.1097/fbp.0b013e328349fc31", "type": "journal-article", "created": {"date-parts": [[2011, 8, 3]], "date-time": "2011-08-03T21:12:50Z", "timestamp": 1312405970000}, "page": "508-515", "source": "Crossref", "is-referenced-by-count": 7, "title": ["Potential serotonin 5-HT1A and dopamine D4 receptor modulation of the discriminative stimulus effects of amphetamine in rats"], "prefix": "10.1097", "volume": "22", "author": [{"given": "Danuta", "family": "Marona-Lewicka", "sequence": "first", "affiliation": []}, {"given": "David E.", "family": "Nichols", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Behavioural Pharmacology"], "language": "en", "link": [{"URL": "http://journals.lww.com/behaviouralpharm/Fulltext/10.1097/FBP.0b013e328349fc31", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 11, 29]], "date-time": "2018-11-29T14:55:05Z", "timestamp": 1543503305000}, "score": 35.915596, "subtitle": [""], "issued": {"date-parts": [[2011, 9]]}, "references-count": 0, "journal-issue": {"issue": "5 and 6"}, "URL": "http://dx.doi.org/10.1097/fbp.0b013e328349fc31", "ISSN": ["0955-8810"], "issn-type": [{"value": "0955-8810", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T21:52:38Z", "timestamp": 1574373158900}, "reference-count": 42, "publisher": "American Society for Pharmacology & Experimental Therapeutics (ASPET)", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Mol Pharmacol"], "published-print": {"date-parts": [[2008, 9]]}, "DOI": "10.1124/mol.108.047472", "type": "journal-article", "created": {"date-parts": [[2008, 6, 5]], "date-time": "2008-06-05T01:19:02Z", "timestamp": 1212628742000}, "page": "544-551", "source": "Crossref", "is-referenced-by-count": 66, "title": ["Ligand-Dependent Oligomerization of Dopamine D2 and Adenosine A2A Receptors in Living Neuronal Cells"], "prefix": "10.1124", "volume": "74", "author": [{"given": "Pierre-Alexandre", "family": "Vidi", "sequence": "first", "affiliation": []}, {"given": "Benjamin R.", "family": "Chemel", "sequence": "additional", "affiliation": []}, {"given": "Chang-Deng", "family": "Hu", "sequence": "additional", "affiliation": []}, {"given": "Val J.", "family": "Watts", "sequence": "additional", "affiliation": []}], "member": "36", "published-online": {"date-parts": [[2008, 6, 4]]}, "reference": [{"key": "2019081413575660000_74.3.544.1", "DOI": "10.1083/jcb.119.3.617", "doi-asserted-by": "publisher"}, {"key": "2019081413575660000_74.3.544.2", "DOI": "10.1124/pr.55.3.2", "doi-asserted-by": "publisher"}, {"key": "2019081413575660000_74.3.544.3", "DOI": "10.1016/j.jns.2006.05.019", "doi-asserted-by": "publisher"}, {"key": "2019081413575660000_74.3.544.4", "DOI": "10.1074/jbc.M006936200", "doi-asserted-by": "publisher"}, {"key": "2019081413575660000_74.3.544.5", "DOI": "10.1016/j.coph.2004.08.001", "doi-asserted-by": "publisher"}, {"key": "2019081413575660000_74.3.544.6", "DOI": "10.1016/j.tips.2005.01.004", "doi-asserted-by": "publisher"}, {"key": "2019081413575660000_74.3.544.7", "DOI": "10.1046/j.1471-4159.2003.02200.x", "doi-asserted-by": "publisher"}, {"key": "2019081413575660000_74.3.544.8", "DOI": "10.1074/jbc.M306451200", "doi-asserted-by": "publisher"}, {"key": "2019081413575660000_74.3.544.9", "volume": "44", "first-page": "950", "year": "1993", "journal-title": "Mol Pharmacol"}, {"key": "2019081413575660000_74.3.544.10", "DOI": "10.1124/pr.59.3.2", "doi-asserted-by": "publisher"}, {"key": "2019081413575660000_74.3.544.11", "DOI": "10.1111/j.1471-4159.2006.04388.x", "doi-asserted-by": "publisher"}, {"key": "2019081413575660000_74.3.544.12", "DOI": "10.1073/pnas.88.16.7238", "doi-asserted-by": "publisher"}, {"key": "2019081413575660000_74.3.544.13", "volume": "271", "first-page": "1574", "year": "1994", "journal-title": "J Pharmacol Exp Ther"}, {"key": "2019081413575660000_74.3.544.14", "DOI": "10.1016/0169-328X(92)90173-9", "doi-asserted-by": "publisher"}, {"key": "2019081413575660000_74.3.544.15", "DOI": "10.1007/s00702-006-0589-0", "doi-asserted-by": "publisher"}, {"key": "2019081413575660000_74.3.544.16", "volume": "270", "first-page": "3928", "year": "2003", "journal-title": "Eur J Biochem", "DOI": "10.1046/j.1432-1033.2003.03773.x", "doi-asserted-by": "crossref"}, {"key": "2019081413575660000_74.3.544.17", "DOI": "10.1073/pnas.0508950102", "doi-asserted-by": "publisher"}, {"key": "2019081413575660000_74.3.544.18", "DOI": "10.1074/jbc.M604390200", "doi-asserted-by": "publisher"}, {"key": "2019081413575660000_74.3.544.19", "DOI": "10.1074/jbc.M107731200", "doi-asserted-by": "publisher"}, {"key": "2019081413575660000_74.3.544.20", "DOI": "10.1016/S1097-2765(02)00496-3", "doi-asserted-by": "publisher"}, {"key": "2019081413575660000_74.3.544.21", "DOI": "10.1038/nbt816", "doi-asserted-by": "publisher"}, {"key": "2019081413575660000_74.3.544.22", "DOI": "10.1124/mol.104.006320", "doi-asserted-by": "publisher"}, {"key": "2019081413575660000_74.3.544.23", "DOI": "10.1016/S0006-291X(03)00991-4", "doi-asserted-by": "publisher"}, {"key": "2019081413575660000_74.3.544.24", "DOI": "10.1124/mol.58.1.120", "doi-asserted-by": "publisher"}, {"key": "2019081413575660000_74.3.544.25", "DOI": "10.1016/j.pneurobio.2007.07.001", "doi-asserted-by": "publisher"}, {"key": "2019081413575660000_74.3.544.26", "DOI": "10.1038/nbt0102-87", "doi-asserted-by": "publisher"}, {"key": "2019081413575660000_74.3.544.27", "DOI": "10.1093/emboj/21.7.1628", "doi-asserted-by": "publisher"}, {"key": "2019081413575660000_74.3.544.28", "DOI": "10.1042/BJ20041361", "doi-asserted-by": "publisher"}, {"key": "2019081413575660000_74.3.544.29", "DOI": "10.1124/pr.59.1.5", "doi-asserted-by": "publisher"}, {"key": "2019081413575660000_74.3.544.30", "volume": "17", "first-page": "1217", "year": "1997", "journal-title": "J Neurosci", "DOI": "10.1523/JNEUROSCI.17-04-01217.1997", "doi-asserted-by": "crossref"}, {"key": "2019081413575660000_74.3.544.31", "DOI": "10.1038/nbt945", "doi-asserted-by": "publisher"}, {"key": "2019081413575660000_74.3.544.32", "DOI": "10.1074/jbc.M403363200", "doi-asserted-by": "publisher"}, {"key": "2019081413575660000_74.3.544.33", "DOI": "10.1016/j.tins.2006.09.004", "doi-asserted-by": "publisher"}, {"key": "2019081413575660000_74.3.544.34", "DOI": "10.1016/j.lfs.2003.09.009", "doi-asserted-by": "publisher"}, {"key": "2019081413575660000_74.3.544.35", "DOI": "10.2144/000112036", "doi-asserted-by": "publisher"}, {"key": "2019081413575660000_74.3.544.36", "volume": "68", "first-page": "568", "year": "2005", "journal-title": "Mol Pharmacol"}, {"key": "2019081413575660000_74.3.544.37", "volume": "65", "first-page": "569", "year": "1995", "journal-title": "J Neurochem"}, {"key": "2019081413575660000_74.3.544.38", "DOI": "10.1074/jbc.M414043200", "doi-asserted-by": "publisher"}, {"key": "2019081413575660000_74.3.544.39", "DOI": "10.1124/jpet.103.057083", "doi-asserted-by": "publisher"}, {"key": "2019081413575660000_74.3.544.40", "volume": "50", "first-page": "966", "year": "1996", "journal-title": "Mol Pharmacol"}, {"key": "2019081413575660000_74.3.544.41", "DOI": "10.1016/j.pep.2006.05.017", "doi-asserted-by": "publisher"}, {"key": "2019081413575660000_74.3.544.42", "volume": "45", "first-page": "878", "year": "1994", "journal-title": "Mol Pharmacol"}], "container-title": ["Molecular Pharmacology"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1124/mol.108.047472", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 8, 14]], "date-time": "2019-08-14T21:04:48Z", "timestamp": 1565816688000}, "score": 35.828472, "issued": {"date-parts": [[2008, 6, 4]]}, "references-count": 42, "journal-issue": {"published-online": {"date-parts": [[2008, 8, 21]]}, "published-print": {"date-parts": [[2008, 9]]}, "issue": "3"}, "alternative-id": ["10.1124/mol.108.047472"], "URL": "http://dx.doi.org/10.1124/mol.108.047472", "relation": {"cites": []}, "ISSN": ["0026-895X", "1521-0111"], "issn-type": [{"value": "0026-895X", "type": "print"}, {"value": "1521-0111", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T13:48:06Z", "timestamp": 1574171286486}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1998, 11, 1]], "date-time": "1998-11-01T00:00:00Z", "timestamp": 909878400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Neuropsychopharmacology"], "published-print": {"date-parts": [[1998, 11]]}, "DOI": "10.1016/s0924-977x(98)80103-x", "type": "journal-article", "created": {"date-parts": [[2003, 8, 12]], "date-time": "2003-08-12T15:29:34Z", "timestamp": 1060702174000}, "page": "S117-S118", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Dopamine D4 receptor gene polymorphism and human behaviors"], "prefix": "10.1016", "volume": "8", "author": [{"given": "J.", "family": "Benjamin", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["European Neuropsychopharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0924977X9880103X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0924977X9880103X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 14]], "date-time": "2019-03-14T19:58:54Z", "timestamp": 1552593534000}, "score": 35.561676, "issued": {"date-parts": [[1998, 11]]}, "references-count": 0, "alternative-id": ["S0924977X9880103X"], "URL": "http://dx.doi.org/10.1016/s0924-977x(98)80103-x", "ISSN": ["0924-977X"], "issn-type": [{"value": "0924-977X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T21:10:37Z", "timestamp": 1574111437082}, "reference-count": 0, "publisher": "American Chemical Society (ACS)", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J. Med. Chem."], "published-print": {"date-parts": [[1996, 1]]}, "DOI": "10.1021/jm950707+", "type": "journal-article", "created": {"date-parts": [[2002, 7, 26]], "date-time": "2002-07-26T06:00:31Z", "timestamp": 1027663231000}, "page": "549-555", "source": "Crossref", "is-referenced-by-count": 41, "title": ["8,9-Dihydroxy-2,3,7,11b-tetrahydro-1H-naph[1,2,3-de]isoquinoline:\u00a0 A Potent Full Dopamine D1Agonist Containing a Rigid \u03b2-Phenyldopamine Pharmacophore"], "prefix": "10.1021", "volume": "39", "author": [{"given": "Debasis", "family": "Ghosh", "sequence": "first", "affiliation": []}, {"given": "Scott E.", "family": "Snyder", "sequence": "additional", "affiliation": []}, {"given": "Val J.", "family": "Watts", "sequence": "additional", "affiliation": []}, {"given": "Richard B.", "family": "Mailman", "sequence": "additional", "affiliation": []}, {"given": "David E.", "family": "Nichols", "sequence": "additional", "affiliation": []}], "member": "316", "container-title": ["Journal of Medicinal Chemistry"], "language": "en", "link": [{"URL": "https://pubs.acs.org/doi/pdf/10.1021/jm950707+", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 29]], "date-time": "2019-09-29T15:20:45Z", "timestamp": 1569770445000}, "score": 35.469498, "issued": {"date-parts": [[1996, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1996, 1]]}, "issue": "2"}, "alternative-id": ["10.1021/jm950707+"], "URL": "http://dx.doi.org/10.1021/jm950707+", "ISSN": ["0022-2623", "1520-4804"], "issn-type": [{"value": "0022-2623", "type": "print"}, {"value": "1520-4804", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T09:36:47Z", "timestamp": 1574501807363}, "reference-count": 25, "publisher": "Elsevier BV", "issue": "21", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2012, 11, 1]], "date-time": "2012-11-01T00:00:00Z", "timestamp": 1351728000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Bioorganic & Medicinal Chemistry"], "published-print": {"date-parts": [[2012, 11]]}, "DOI": "10.1016/j.bmc.2012.08.058", "type": "journal-article", "created": {"date-parts": [[2012, 9, 8]], "date-time": "2012-09-08T15:01:02Z", "timestamp": 1347116462000}, "page": "6366-6374", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Identification of a 2-phenyl-substituted octahydrobenzo[f]quinoline as a dopamine D3 receptor-selective full agonist ligand"], "prefix": "10.1016", "volume": "20", "author": [{"given": "Alia H.", "family": "Clark", "sequence": "first", "affiliation": []}, {"given": "John D.", "family": "McCorvy", "sequence": "additional", "affiliation": []}, {"given": "Jason M.", "family": "Conley", "sequence": "additional", "affiliation": []}, {"given": "Whitney K.", "family": "Williams", "sequence": "additional", "affiliation": []}, {"given": "Markondaiah", "family": "Bekkam", "sequence": "additional", "affiliation": []}, {"given": "Val J.", "family": "Watts", "sequence": "additional", "affiliation": []}, {"given": "David E.", "family": "Nichols", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Bioorganic & Medicinal Chemistry"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0968089612006955?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0968089612006955?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 7, 3]], "date-time": "2019-07-03T16:22:46Z", "timestamp": 1562170966000}, "score": 34.992043, "issued": {"date-parts": [[2012, 11]]}, "references-count": 25, "journal-issue": {"published-print": {"date-parts": [[2012, 11]]}, "issue": "21"}, "alternative-id": ["S0968089612006955"], "URL": "http://dx.doi.org/10.1016/j.bmc.2012.08.058", "ISSN": ["0968-0896"], "issn-type": [{"value": "0968-0896", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T13:47:06Z", "timestamp": 1574344026115}, "reference-count": 52, "publisher": "Elsevier", "isbn-type": [{"value": "9780080552323", "type": "print"}], "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2007, 1, 1]], "date-time": "2007-01-01T00:00:00Z", "timestamp": 1167609600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2007]]}, "DOI": "10.1016/b978-008055232-3.60158-8", "type": "book-chapter", "created": {"date-parts": [[2008, 1, 10]], "date-time": "2008-01-10T20:30:57Z", "timestamp": 1199997057000}, "page": "1-12", "source": "Crossref", "is-referenced-by-count": 0, "title": ["D4 Dopamine Receptor"], "prefix": "10.1016", "author": [{"given": "Kim", "family": "Neve", "sequence": "first", "affiliation": []}, {"given": "David R.", "family": "Sibley", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["xPharm: The Comprehensive Pharmacology Reference"], "link": [{"URL": "https://api.elsevier.com/content/article/PII:B9780080552323601588?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:B9780080552323601588?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 5, 6]], "date-time": "2019-05-06T19:52:57Z", "timestamp": 1557172377000}, "score": 34.431316, "issued": {"date-parts": [[2007]]}, "ISBN": ["9780080552323"], "references-count": 52, "URL": "http://dx.doi.org/10.1016/b978-008055232-3.60158-8"}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}